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1.1 Radiotherapy 
Radiotherapy is widely used for the treatment of cancer, either as a single modality or 
in combination with other treatments, like surgery or chemotherapy. The aim of 
radiotherapy is the eradication of tumor cells by means of ionizing radiation. Radiation 
can induce, either directly or indirectly, irreparable DNA damage in the cells, resulting 
in cellular kill directly or in a so-called apoptosis, i.e. cellular suicide. Because 
radiation damage is not restricted to tumor cells only, but affects normal cells as well, it 
is essential that the dose delivered to healthy tissues is as low as achievable to 
minimize the risk of side effects of the treatment. 
Most frequently, radiation is delivered by external beam radiotherapy using a linear 
accelerator. For this kind of radiotherapy, possibilities to minimize the dose delivery to 
normal tissues have largely been extended in the past few decades. First of all, the 
introduction of CT, and later MRI, allowed for a more accurate definition of tumor 
volumes and sensitive structures. Secondly, the availability of user-friendly and fast, 
3D treatment planning tools extended the possibilities to optimize treatment plans for a 
particular patient within a reasonable time, by a proper, manual selection of the number 
of treatment fields and, for each particular field, the beam direction, energy, weight 
and, if necessary, wedge angle. Thirdly, after introduction of multileaf collimators 
(MLC) the shape of treatment fields could be conformed easily and fast to the beam's 
eye view projection of the tumor volume, thereby reducing the dose delivelY to 
sUlTounding healthy tissues [112]. Finally, investigations on computer optimization of 
radiotherapy treatment planning demonstrated that dose distributions could often be 
conformed more tightly to a target volume by customizing the beam intensity profiles 
within the treatment field (intensity modulated radiotherapy (IMRT)). The use of 
patient-specific intensity modulated beams makes it possible to correct for variations in 
patient contours and for tissue inhomogeneities. It allows for the generation of concave 
shaped dose distributions and the sparing of organs at risk in complex treatment 
geometries. For calculation of intensity modulated beam profiles, different inverse 
treatment planning techniques have been proposed in the literature [12,16,17,56,68,91, 
104,114,134,137,164,166-168), but improved treatment plans using beam intensity 
modulation have also been realized by advanced, computer-assisted forward planning 
techniques [36,36,50). 
Treatment planning techniques aiming at tailoring the high dose volume strictly to the 
tumor volume, while simultaneously delivering as Iowa radiation dose as possible to 
surrounding normal structures are classified as 3D conformal radiotherapy. A main 
impact of conformal radiotherapy is that it allolVs for a reduction in the dose delivered 
to sensitive healthy tissues, thereby reducing the risk of (severe) side effects, like 
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xerostomia in the treatment of head and neck cancer. For other tumors, like lung cancer 
and prostate cancer, application of advanced conformal treatment techniques makes 
escalation of the target dose possible, without increasing the risk of normal tissue 
complications, in an attempt to improve the probability of local tumor control and 
overall survival [86]. 
1.2 Realization of intensity modulated beam profiles 
Patient-specific intensity modulated beam profiles can be realized in several ways. A 
rather straightforward method is the use of compensators [66], but tltis has several 
drawbacks. First of all, their production is labor-intensive. Since they have to be 
changed manually for each treatment field, their use is time consunting during 
treatment delivery as well. For this reason, only a limited number of compensators can 
generally be used in clinical practice. Another drawback is the need for models to 
accurately include scattered photons and beam hardening, as produced by the 
compensators, in the dose calculations. 
As an alternative, several methods for realization of intensity modulated beams using a 
multileaf collimator have been suggested. Bortfeld ef al [13] and Galvin e/ al [51] have 
investigated the use of static multileaf collimation. This technique is based on the 
superpositioning of a number of partially overlapping, static, inegularly shaped MLC 
fields. A second technique is the use of dynantic multileaf collimation. So far the 
'sliding window' technique has received most attention in the literature. This technique 
is based on the independent movement of leaf pairs across the treatment field while the 
radiation is on, effectively sweeping apertures of variable widths across the field [29, 
135,138,147]. Convery and Roosenbloom [29] published the basic algorithm to derive 
leaf motions to realize an optintized intensity modulated prome. Faster, analytical 
solutions to the problem were independently published by Spirou ef al [135], Stein e/ al 
[138] and Svensson ef al [147]. 
At the MM50 Racetrack Microtron, described in the next section, beam intensity 
modulation can also be realized by using scanning photon beams. Due to the width of 
the scanned photon beams (10 cm for a 50 MV beam [11,148], and even larger for 
lower energies), only fields with moderate gradients can presently be realized by beam 
scanning alone. For the 50 MV photon beam the capability of beam scanning to deliver 
more heterogeneous dose distributions could be improved by replacing the standard 
W ICu target by a 3 nnn thick Be target, reducing the width of the scanned photon 
beams to 3.5 cm only [148]. Beam scanning may effectively be used in combination 
with dynantic multileaf collimation, first adjusting as good as possible the incoming 
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fluence profile to the optimized fluence profile by beam scanning, after which dynamic 
multileaf collimation is required for fine adjustments only [57,136]. In this way, the 
time required for an IMRT treatment may be reduced significantly with respect to the 
use of dynamic multileaf collimation alone, but the complexity of the treatment is 
increased significantly. 
A special kind of collimator which has been implemented clinically for the realization 
of intensity modulated beam profiles is the Peacock MiMiC [22,55]. This device 
produces a fan beam (1.7 or 3.4 cm wide) with an intensity profile that is modulated 
continuously while rotating the ganhy. Generally, this fan beam does not cover the 
entire PTV in one gantry rotation, requiring the treatment couch with the patient to be 
moved precisely along the axis of rotation after each ganhy rotation. For larger tumors, 
this results in much longer treatment times than are presently used in most radiotherapy 
departments. 
A similar approach, which is still in a developmental phase, is the tomotherapy unit 
described by Mackie ef al [102,103]. Like the Peacock system, the tomotherapy unit 
uses a fan-beam for irradiation of the patients. However, while in the Peacock system 
patients are sequentially irradiated and translated, radiation and translation take place 
simultaneously in the tomotherapy unit, similar to a spiral scans CT. An advantage of 
this technique is that the risk of underdosages due to beam-junction artifacts will be 
reduced. Another important issue is that a CT capability will be available in the 
tomotherapy unit, providing accurate information for patient set-up verification [49] 
and allowing for a reconstmction of the actual dose distribution delivered to a patient 
[109]. 
Yu ef (II [176] introduced the concept of intensity modulated arc therapy (!MAT). 
Instead of using a slit beam to treat a patient slice by slice, IMA T uses MLC-shaped 
fields, which change shape during gantry rotation. By employing multiple arc rotations, 
an optimized intensity profile is delivered from each gantry angle. For most clinical 
sites generally less than five arc rotations are required [15,178]. 
1.3 The MM50 Racetrack Microtron 
An on-going research project involving the development and clinical introduction of 
conformal radiotherapy was started in the Daniel den Hoed Cancer Center at the time 
of the clinical introduction of a dual gantry MM50 Racetrack Microtron [70,93,105, 
108,130] in March 1994. This device, manufactured by Scanditronix Medical AB, is a 
fully computer-controlled treatment unit, suited for advanced three-dimensional 
conformal radiation techniques. Photon beams in the range of 10 up to 50 MV can be 
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produced in steps of 5 MV. Electron beams are available from 7.5 up to 50 MeV in 
steps of 2.5 MeV. Flat beam profiles are created by scanning of elementary beams 
according to fixed scanning patterns. Due to the beam scanning, flattening filters for 
photon beams can be omitted or be very thin, yielding extremely flat beam profiles at 
all depths [70,93]. For electron beams, the scattering foil is very thin due to the 
scanning beam principle [69]. In combination with the helium atmosphere in the 
treatment head, this enables the use of isocentric irradiation techniques, applying the 
double focussed multileaf collimator for beam shaping, like for photon beams [46,71]. 
The MM50 can be used in a fully computer-controlled multi-segment treatment mode 
[38,105]. Using tIus mode only the set-up of the fust segment (field) of a patient treatment 
needs direct interference of the technicians; all parameters of the next segments, like the 
gantry and colllinator angles, couch positions, field shape, beam energy and monitor 
units, are set-up by the treatment computer. Custonuzed intensity modulated beams can 
be generated by computer-controlled superpositiOlung of MLC-defined fields (static 
intensity modulation), by scanning of elementary beams according to individualized 
scamung patterns and by dynamic multileaf collimation [28,57,135,136,147,158]. 
1.4 Objective of this study 
In the past decade much attention has been paid to the development of algorithms to 
calculate cllstonuzed intensity modulated beam profiles for a particular patient by using 
inverse treatment planning tecllluques [12,16,17,56,68,91,104,114,134,137,164, 166-
168]. On the other hand, clinical implementation of intensity modulated treatments, 
with one of the techniques described in section 1.2, has just been started in a linuted 
number of institutes around the world. 
The main objective of this study was the development and clinical implementation of 
intensity modulated conformal radiation techniques on the MM50 Racetrack Microtron 
using the multileaf collimator. Both techniques for static and dynamic beam intensity 
modulation using a multileaf collimator have been investigated. 
For complex treatment machines like the MM50 and for advanced treatment techniques 
using intensity modulation, more extensive quality control is definitely required to 
ensure accurate and safe dose delivery to the patients. Therefore, a second Objective of 
this work was the development of fast methods for dosimetric quality control using a 
camera based fluoroscopic electronic portal imaging device (EPID), as part of the 
overall quality control system. 
Chapter 2 describes a daily dosimetrical quality control procedure for the MM50, 
verifying the output (cGy/MU) and the beam profile for open and wedged fields of 
6 Chapter I 
scanning photon beams at different gantry angles. The suitability of the applied EPID 
for dosimetrical quality control is demonstrated. 
In chapters 3 and 4 a technique for penumbra enhancement is presented using static 
beam intensity modulation (BlM) with a multileaf collimator, which allows for a 
reduction in the field length of all treatment fields used for co-planar treatments of 
prostate and lung cancer patients in our clinic. Based on 3D treatment planning, the 
benefits of this new technique in terms of dose delivery to the target volume and the 
normal tissues were assessed by comparison with our standard technique without BlM. 
Dose measurements were pelformed to assess the dosimetrical accuracy of the 
technique. Due to the limited accuracy of our treatment planning system in lung tissue, 
special attention had to be paid to the use of BlM for the treatment of lung cancer 
patients. Therefore, a more extensive dosimetrical study, which is presented in chapter 
5, was performed on the use of BlM for tlus tumor site. 
Chapter 6 describes an algorithm for the calculation of the required leaf trajectories to 
generate optitnized intensity modulated beam profiles by means of dynamic multileaf 
collimation. In addition to algorithms published before [135,138,147,158], leaf 
transmission and collimator scatter were included and tongue-and-groove 
underdosages were fully avoided. The accuracy of tlus method in combination with our 
treatment planning system was assessed based on absolute dose measurements. 
Before implementing dynamic multileaf collimation in clinical practice, tests were 
performed to investigate the stability of intensity modulated beam profiles realized with 
DMLC. Based on the results, described in chapter 7, the effects of gravity and of 
acceleration and deceleration of the leaves on the stability of the delivered dose profiles 
were derived. 
Chapter 8 deals with a procedure for pre-treatment verification for each individual 
patient of absolute, intensity modulated beam profiles, realized using dynanuc multileaf 
collimation, by applying our EPlD. In contrast to previously published methods 
[5,65,100,118], this procedure sitnultaneously verifies (i) the calculation of the dose 
distribution by the treatment planning system, resulting from the derived leaf 
trajectories, (ii) the transfer of the leaf sequencing file to the treatment unit, and (iii) the 
mechanical and dosimetrical performance of the treatment machine. 
Finally in chapter 9 a general discussion on the use of IMRT in clinical practice is 
presented. 
Chapter 2 
Daily dosimetric quality control of the MM50 Racetrack 
Microtron using an Electronic Portal Imaging Device 
Adopted tram the original article by MLP Dirkx, M Kraollwijk, IeI de Boer 
and BJM Heijmell published ill Radio/her. Ol/col. 37: 55-60, 1995. 
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2.1 Introduction 
The dual gautry MM50 Racetrack Microtron that has been installed in the Daniel den 
Hoed Cancer Center consists of a separate electron accelerator and two gantries. 
Through an evacuated beam line of about 6 meters the accelerated electrons are 
transported to one of both gantries where clinical photon and electron beams arc 
generated by computer-controHed scanning of elementary beams according to fixed 
scanning patterns [69,70]. A constant flow of a helium/nitrogen mixture (99% He, 1% 
N,) mns through the MM50 monitor chambers and the treatment heads to reduce 
electron scattering, yielding very narrow elementary electron beams [69]. 
The complex lay-out with a separate accelerator serving two gantries, the application of 
beam scanning and the continuous gas flow through the monitor chamber and the 
treatment head definitely require a daily dosimetric quality control program in addition 
to more extensive checks on a two weekly basis. Therefore a method has been devel-
oped to performj{lst, dosimetric checks under different gantry angles using the Philips 
SRI-JOO electronic portal imaging device (EPID) fitted to each of both gantries of the 
MM50. Measurements take place every morning before patient treatment starts. 
This chapter deals with a description of the daily quality control measurements and 
demonstrates the suitability of the EPID for this purpose. The stability of the absolute 
output and the relative fluence profile of the 25 MV scanned photon beam of the 
MM50 has been assessed. A protocol for quality control measurements, based on the 
results of this stl.ldy, is described. 
2.2 Materials and methods 
2.2.1 The electronic portal imaging device 
The SRI-IOO is a fluoroscopic system: radiation incident on a fluorescent screen (at a 
distance of 160 cm from the focus) is converted into an optical image, which is 
digitized using a CCD camera. The CCD-chip consists of 512 x 256 pixels, with a 
pixel size projected at isocenterl of about 0.05 x 0.08 cm', resulting in a maximum 
field size of 25 x 19 em' for imaging. In order to improve the signal to noise ratio, the 
signals of the CCD camera are accumulated on the CCD-chip and averaged in a frame 
grabber. The final image is stored in a PC using gray scale values in the range of 0 to 
All pixel and field sizes mentioned in this thesis are defined at isocenter level, 
i.e. at a distance of JOO cm from the focus. 
Daily dosimetric quality control of tile MM50 using an BPIO 9 
255. The technical details of the EPID have been described by Visser et al [163]. 
Prerequisites for dosimetric quality control measurements with an EPID are adequate 
reproducibility, stability and linearity of the measured gray scale values. To ensure the 
response of the EPID, defined as the ratio of a measured gray scale value and the 
applied portal dose, to be as unequivocal as possible, some precautions have been 
taken. The gain and offset of the CCD camera have been set to fixed values and a fixed 
data acquisition time has been used. In addition, the llnages have only been corrected 
for dark current, which is measured just before llTadiation starts. 
The fluorescent screen of the EPID is a 0.165 cm thick stainless steel plate coated with 
a fluorescent layer [163]. For a 25 MV photon beam this screen is not thick enough to 
establish a full charged particle build-up. In the present study this is not a problem 
since the EPID has only been used for dosimetric constancy checks. 
A fixed field size of 18 x 18 em' has been used for all measurements in this study. For 
data reduction, average gray scale values have been calculated for 49 areas of 1.5 x 1.5 
cm
2 inside the measured EPID-image, yielding dosimetric data for the beam axis and 
for 48 off-axis points (see figure 2.1). All software used for acquiring and analyzing 
the images has been written in the macro conunand language of the SRI- I 00 system. 
In addition to the daily dosimetric checks with the EPID for the 18 x 18 cm' field, the 
field flatness and symmetry are also checked for the maximum field size (31 x 40 cm') 
as part of aliI' two weekly quality control program. These measurements are performed 
along the two main axes using a linear detector array consisting of 32 ionization 
chambers. 
2.2.2 Reproducibility, stability and linearity of the EPID 
The reproducibility, stability and linearity of the EPID have been assessed by 
comparing measured gray scale values with absolute dose measurements at the beam 
axis. The dose measuremcnts were performed with a NE-2571 ionization chamber in a 
PMMA phantom at the depth of maximum dose with a source to surface distance of 
100 cm. Since EPID and ionization chamber measurements could not be performed 
simultaneously, the two types of measuremcnts were always performed sequentially, 
keeping the interval time as short as possible. 
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2.2.3 Daily quality control measurements 
For the open 25 MY scanning photon beam, EPID images were obtained on a daily 
basis for four different gantry angles (0, 90, 180 and 270 degrees). For gantry angle 0, 
a 60° wedged field image was measured as well to verify the wedge position and to 
check the beam penetrative quality. All images were acquired using a flxed dose of 150 
monitor units. The flve flelds (four open fields and one wedged field) were set-up 
under computer control using the MM50 multi-segment treatment mode which was 
described in chapter 1.3. 
To determine deviations in the absolute beam output and in the relative 2D fluence 
profile, each image has been compared with a corresponding reference image. This 
reference image refiects the absolute 2D fiuence profile at the time of beam 
commissioning for a fixed dose of 150 MU and a cGy/MU value of I for the 10 x 10 
cm' field. Both the absolute output and the 2D fiuence profile of the 25 MY photon 
beam of the MM50 are slightly gantry angle dependent. For clinical practice these 
dependencies are within acceptable levels and for treatment planning the beam data for 
gantry angle 0 are used. The use of a separate reference image for each field in the 
daily dosimetric constancy checks eases a fast interpretation of these measurements: for 
each field, constancy means zero deviations with regard to its corresponding reference 
image. 
For each of the 49 areas defined in the measured images, the percentual difference in 
measured gray scale value compared to the corresponding area in the related reference 
image has been determined. Figure 2.1 shows the screen output of a typical 
measurement. Observed differences at the beam axis (1.4% in this example) relate to 
deviations in the absolute output of the photon beam. Deviations in the relative 2D 
fiuence profile have been determined by correcting the 49 percentual differences for 
the observed deviation in absolute output at the beam axis (compare flgures 2.1 and 
2.2). 
Figure 2.1 
Figure 2.2 
Daily dosimetric quality control of the MM50 using all BPID 11 
Screen output showing the definition of Ihe 49 areas of 1.5x1.5 CJIl2 in all 
EPID-image. The Ilumbers represent all example of obsell/ed percenlual 
deviatiolls of measured absolute gray scale values from Ihe corre~poJldiJlg 
values ill Ihe related reference image. 
PerceJltual deviations in the relative 2D jluence profile from Ihe reference 
image, derived by rellormalizatioJl of the data ill figure 2.1, assllming zero 
deviation al Ihe beam axis. 
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2.3 Results and discussion 
2.3.1 Reproducibility, stability and linearity of the EPID 
The short term reproducibility of dosimelric EPID-measurements has been assessed by 
sequential measurement of images and ionization chamber readings at the beam axis 
under identical conditions in a short overall period of time (typically 15 minutes). Both 
for the on-axis and oft~axis points the EPID-measurements show a reproducibility of 
the measured gray scale values of 0.5% (l SO); the fluctuations in the ionization 
chamber readings were negligible. A significant correlation exists between on-axis and 
off-axis fluctuations: after correcting the gray scale values in the off-axis points for the 
observed on-axis flucnmtions, the remaining image-to-image variation for off-axis 
points decreases to only 0.2% (l SO). 
To assess the day-to-day sensitivity stability of the SRI-IOO, its response al Ihe beam 
axis has been determined, usually twice a day, for a period of twenty days. 
Measurements of one EPID-image and a few ionization chamber readings were 
performed for gantry angle 0 in a short overall period of time. The results depicted in 
figure 2.3 reveal a variation in the on-axis EPID-response of 0.6% (l SO), which is 
only slightly larger than the above menlioned short-term reproducibility. 
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Figure 2.3 Day-to-day OJI-ax;s sensitivity stability a/tile EPID. 
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To assess the long-term sensitivity stability of the SRI-IOO, the response measurements 
have been repeated in a second period of twenty days. Thc time interval between the 
first and the second period was 60 days. Also for this second period a variation in the 
EPID-response of 0.6% (I SO) was measured. However, the average response in the 
second period was 0.5% lower than in the first period, probably due to radiation 
damage in the CCO-chip. 
The linearity of the EPID has been assessed for doses between 40 and 180 monitor 
units (MU). From the results in figure 2.4, showing the measured response at the beam 
axis as a function of MU, it is clear that the response does not significantly depend on 
the applied dose. In other words, the measured gray scale value increases linearly with 
the delivered dose. 
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Figure 2.4 Linearity of the measured gray scale value with applied portal dose. 
It may be concluded that the SRI-IOO is suitable for daily dosimetric quality control 
measurements. No adverse interference effects related to the combined use of the 
MM50 scauning beams and the slow scan mode of the CCO-camera have been 
observed. For at least a period of several weeks it is possible to derive the output at the 
beam axis from a sillgle EPID-measurement with an accuracy of 0.6% (I SO), while 
the relative 20 fluence profile can be determined even more accurately. After a period 
of several weeks a recalibration of the EPID might be necessary to corrcct for changes 
in sensitivity. 
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2.3.2 Daily quality control measurements 
The observed deviations in absolute on-axis output for gantry angle 0, measured with 
the EPID during a period of 300 days, are depicted in figure 2.5. The sudden change in 
output deviation on day 142 is related to a recalibration of the MM50 monitor chamber. 
Table 2.1 summarizes the results of 1300 measured images, equally spread over the 
five different fields. 
Figure 2.5 
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Deviations ;11 absolute Oil-axis output of the 25 MV plioton beam, 
measured with the EPID for gmw)' (Ingle O. The deviation of 6% has 
been omitted (see text forfurther e.\planatioll). 
Once an output deviation of about 6% was detected for each field. (In order to stick to 
an appropriate ordinate scale in figure 2.5, this value has not been included). Checks 
with an ionization chamber showed an output deviation of the same amount. This 1arge 
deviation was a consequence of a human error related with the helium/nitrogen flow in 
the monitor chamber. For historical reasons two separate bottles are used to supply 
each gantry with this mixture: one while the MM50-system is switched on, the other 
when the system is off. During the weekend the 'system-off bottle' for one gantry 
became empty because the responsible person forgot to change it before the weekend. 
For this reason the constant gas flow stopped, the ovel}Jressure in the treatment head 
went down and air could leak into the treatment head and therefore also into the 
monitor chamber. When the machine was switched on after the weekend, the 'system-
Table 2.1 
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Overview of observed deviations from corresponding reference images. The 
incidence rates indicate the percentage of the total Humber of analyzed 
fields (N::::; 1300) ill which a certain de\'iatioll occurred. 
deviations incidence rate 
absolute on-axis output deviations <±2.0 % 94 % 
±(2.0 - 3.0)% 5% 
>±3.0% 1% 
average off-axis profile deviations < ±0.3 % 94.7% 
±(0.3 - 0.5)% 5% 
>±0.5 % 0.3 % 
maximum off-axis profile deviations < ±1.5 % 89% 
±( 1.5 - 2.0)% 10% 
>+2.0% 1% 
on bottle' was automatically connected to the monitor chamber. At that moment the 
MM50 system observed correct input and return gas flows (since the 'system-on bottle' 
was not empty) and no interlock occurred. However, it took several hours before all air 
had disappeared from the monitor chamber, yielding an increased sensitivity of this 
chamber and therefore a 6% too low beam output. 
The observed average and maximum deviations in the relative 2D beam profile, 
determined from the measurements in the 48 off-axis points, are depicted in figure 2.6 
for gantry angle 0 and summarized in table 2.1 for all fields. Because the average off-
axis deviation was always less than 0.6% and the maximum observed off-axis deviation 
was 2.8%, it may be concluded that the relative 20 fluence profile is very stable. 
Wedge factors have been calculated from measured gray scale values at the beam axis 
for the open and the wedged field at gantry angle O. The results, depicted in figure 2.7, 
show a constancy of 0.7% (I SO). 
On se\Ieral days, the morning quality control measurements were repeated in the 
afternoon after patient treatment. No significant differences between results obtained in 
the morning and in the afternoon have been observed. 
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Figure 2.6 Off-axis de\';atiolls ill the relative 2D beam profiles for gall/I)' angle O. 
The dols indicate the average off-axis deviations for the 48 off-axis points, 
the bars indicate the maximum deviations. 
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2.3.3 Protocol for daily quality control measurements 
Based on the results in table 2.1 and on clinical requirements regarding acceptability of 
deviations, the following practical protocol for daily dosimetric quality control 
measurements has been adopted: 
If 
and 
and 
and 
* 
for each field the on-axis output deviation is smaller than 3%, . 
for the five fields the average output deviation at the beam axis is less than 2%, 
or between 2% and 2.5% while being below the 2%-level the previous two 
days, 
for each field the maximum off-axis beam profile deviation is less than 2%, or 
between 2% and 2.5% while being below the 2%-level the previous two days, 
for each field the average off-axis deviation is less than 0.5%, or between 0.5% 
and 0.7% while being below the 0.5%-level the previous two days, 
the results are accepted and patient treatment can start. 
In all other cases, additional investigations and, if necessary, adjustment of the beam 
characteristics have to be performed. When this protocol had been applied to the daily 
quality control measurements described before, patient treatment could have started 
innuediately on 95% of the days. 
Daily EPID measurements should be fast. Therefore, only one unage is measured per 
tleld and the allowed deviations, as described in the protocol above, arc somewhat 
larger than for the checks in our two weekly quality control program. 
2.4 Conclusions 
Because of its characteristics, the Philips SRI-IOO Electronic Portal Imaging Device is 
suitable for fast and accurate daily dosimetric quality control of photon beams under 
different gantty angles. Deviations in the absolute output and in the relative 20 fluence 
profiles are determined within ten minutes for five fields. 
Despite the complexity of the MM50, the 20 fluence profile of the 25 MY scanned 
photon beam has been very stable for all gantry angles during a period of 10 months: a 
maximum profile deviation of 2.8% was observed and the average profile deviation 
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never exceeded 0.6%. Once, a deviation in the cGylMU-value of 6% has been 
detected. Gnly because of the performed morning quality control checks, erroneous 
dose delivery to patients could be avoided. Based on our experiences, a practical 
protocol for daily dosimetric quality control measurements has been developed. 
This chapter is based on the results of measurements for the 25 MV photon beam of 
one gantry. However, in the meantime the dosimetric checks are also successfully 
performed at the other gantry. Moreover, the quality control measurements have been 
extended to the 10 MV photon beam. Studies on the application of a fluoroscopic 
portal imaging device for in-vivo dosimetry on the MM50 are in progress [76,77,118-
121,123]. 
Chapter 3 
Field margin reduction using intensity modulated X-ray beams 
formed with a multileaf collimator 
Adopted from the original article by MLP Dirkx, BIM Heijmen, GA Korevaar, 
MJH van as, IC Stroom, PCM Koper and PC Levendag, published in Illf. 1. 
Radiat. Ollcol. Bioi. Phys. 38: 1123-1127, 1997. 
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3.1 Introduction 
In the Daniel den Hoed Cancer Center, prostate cancer patients are treated at the 
MM50 Racetrack Microtron with a 25 MV photon beam. An isocentric technique is 
used with one open anterior field and two lateral oblique fields, which are partly 
delivered with a 60° (motor) wedge inserted. The lateral oblique fields are slightly 
tilted posteriorly in order to minimize the irradiated rectal volume. All fields contribute 
equally to the dose in the isocenter. Beam shaping is performed with a multi leaf 
collimator. The intention is to comply with the ICRU-50 recommendations for dose 
homogeneity [62]: the dose in the 3D PTV is aimed to be between -5% and +7% of the 
dose in the ICRU-point, i.e. the isocenter. To avoid doses in the PTV of less than 95% 
resulting from beam penumbrae, beam apertures are defined by adding field margins to 
the beam's-eye-view projections of the PTV. For all patients, field margins of 0.5 cm 
and 0.7 cm for, respectively, the lateral borders of the anterior field and the anterior 
and posterior borders of the lateral oblique fields are sufficient to meet the ICRU-50 
reco1l1111eudations. However, even a field margin of 1.5 em for definition of the 
superior and inferior field borders of all fields still yields small underdosages « 2%) in 
the superior and inferior ends of the PTV for nearly all patients. In these cases, 1.5 cm 
margins are used and the underdosages are accepted. Relatively large field margins for 
definition of the superior and inferior field borders for treatment of prostate cancer 
patients have also been reported by Leibel et al [861. 
Recently, Chen et al [25] and Mohan et al [113] have investigated the influence of 
phantom scatter on the design of optimized intensity modulated beams; phantom scatter 
is one of the main causes for the generally observed large 50-95% penumbra width of 
photon beams. They found that extra beam intensity ncar the beam boundaries could 
compensate for beam penumbra effects, yielding a more homogeneous irradiation of 
the PTV and providing a better protection for normal tissues. For multiple field, axial 
treatments, extra beam intensity was especially needed ncar the superior and inferior 
field borders; this observation was attributed to the overlap of penumbrae of all 
involved treatment fields at the superior and inferior ends of the PTV. 
Several devices have been used to reduce the 50-95% penumbra width of X-ray beams. 
Biggs and Shipley [9] have described the use of lead filters in a 25 MV photon beam, 
which were positioned in the center part of the fields. In this way the dose in the center 
of the beam was attenuated relative to the dose in the beam edges, improving the 50-
95% penumbra width with 0.4 to 0.7 cm, depending on the field size. For a 4 MV 
accelerator, improvements in the flatness and the penumbra of small fields (up to 
10xi0 cm') have been reported using special tungsten alIa)' trimmers, attached to a tray 
below the accelerator head [116], The lead filters used by Biggs and Shipley have some 
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disadvantages: for each patient and each treatment field, a separate filter has to be 
produced. Moreover, in between treatment fields the technicians have to enter the treat-
ment room in order to change the filters. The use of the tungsten alloy trimmers is 
restricted to rectangular fields. 
In this chapter we report on a method for treatment of prostate cancer patients applying 
intensity modulated (1M) X-ray beams with increased intensity near the superior and 
inferior field borders in order to reduce the distance between the 50 and 95% isodose 
surfaces. The intensity modulated beams, produced with a multileaf collimator, include 
narrow, low weight boost fields superimposed on the superior and inferior ends of 
regular flat fields. The development of the IM technique was aimed to achieve a 
reduction in the superior-inferior field length. The technique should meet three 
constraints: (i) the minimum dose in the entire PTY should be 95% of the isocenter 
dose, (ii) compared to our standard technique, increases in the maximum rectal and 
bladder doses should be avoided as much as possible, and (iii) treatment planning and 
clinical application of the IM technique should be simple, safe and not time consuming. 
Using 3D treatment plans, the benefits of the technique are demonstrated for ten 
prostate cancer patients. The accuracy of the dose calculation algorithm in our 
treatment planning system for the narrow boost fields has been determined by 
comparison with measurements. For treatments at the M50 Racetrack Microtron. the 
extra time needed for delivery of the boost fields has been assessed. 
3.2 Materials and methods 
3.2.1 Intensity modulated X-ray beams for treatment of prostate cancer 
patients: the applied technique 
With respect to our standard three field technique, described in the introduction, only 
two changes are made for the 1M technique: 1) for all three involved fields the field 
margin for definition of the superior and inferior field borders is fixed at 0.7 cm instead 
of the usual 1.5 cm, and 2) narrow, low weight boost fields are superimposed on the 
superior and inferior ends of each of the two lateral oblique fields such that the 
minimum dose in the superior and inferior ends of the PTY just exceeds the 95% level. 
For field margins smaller than 0.7 cm, a minimum PTV dose of 95% could generally 
only be achieved at the cost of an increase in the maximum doses delivered to the 
rectum and the bladder. 
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Figllre 3.1 
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Right lateral obliqllefieldsfor treatlllent of patient 4 in table 3.1.-
(a) for the standard technique lIsing field margins ill superior-inferior 
direction of 1.5 CIII; (bi for the 1M techniqlle, i.e. slIperior-inferiar field 
margins of O. 7 em alld addition of a superior (lnd alt il{ferior boost field. 
For both lateral oblique beam orientations, the superior and inferior boost fields are 
generally delivered simultaneously by closing leaf pairs in the central part of the beam 
while keeping the position of the collimator blocks fixed. See figure 3.1 for an 
example. To be able to compensate for variations in the patient contour in superior-
inferior direction, possibly yielding an increased maximum dose in the rectum or the 
bladder, the two fields can also be delivered sequentially (see below). 
For each patient, all four boost fields have the same superior-inferior length I, obeying 
the equation 1=(L-II'1I')I2, with L the field length as defined by the collimator blocks, II 
the number of central leaf pairs that are closed and 11' the leaf width (1.25 cm at 
isocenter for the MM50 Racetrack Microtron), L is fully determined by the superior-
inferior PTV length and the applied fixed field margin of 0.7 cm. As a consequence, 
for each patient, possible lengths I of the boost fields differ by multiples of 11'12 cm, 
depending on the choice of n in the equation above. Based on a large number of 
treatment plans, it was concluded that I should preferably be in the range 1.1 to 1.6 cm. 
Often, a smaller field length yielded underdosages in the PTV in CT -slices situated 
next to the most superior and inferior slices with PTV; larger lengths I could lead to 
unwanted increases in the maximum dose delivered to the rectum or the bladder. For 
each patient, only one I can fulfil both equations 1=(L-Il-w)/2 and 1.1 Clll gO; 1.6 CIll. 
For the patients in this study, each with a different PTV length, the length I of the 
applied boost fields for the design of the final 1M plan is presented in table 3.1. 
Table 3.1 
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The slIperior-illferior length of the applied boost fields as a fill/ction of tlte 
length of the PTV ill superior-inferior dh'ectioJ1. 
patient length PTV ( cm) length boost fields ( cm) 
I 7.5 1.3 
2 8.0 1.6 
3 8.5 1.2 
4 9.0 1.5 
5 9.5 1.1 
6 10.0 1.3 
7 10.5 1.6 
8 11.0 1.2 
9 11.5 1.5 
10 12.0 1.1 
The only real variables in treatment planning are the weights of the boost fields and the 
choice whether or not to deliver the superior and inferior boost fields simultaneously 
(see above). In practice, for each patient, the design of the 1M-technique starts with a 
treatment plan based on a simultaneous delivery of the superior and inferior boost 
fields for each of the two lateral oblique fields. The weight of the boost fields is such 
that for both the superior and the inferior ends of the PTV, the delivered dose is at least 
95% of the isocenter dose. In case the obtained minimum dose in the most superior or 
the most inferior parts of the PTV is higher than 95% (e.g. due to variations in patient 
contour in superior-inferior direction), a modified plan, based on a sequential delivery 
of the superior and inferior boost fields for one of the two lateral oblique fields with 
slightly different weights, is considered. 
At the MM50 Racetrack Microtron overtravel of the collimator blocks across the 
central axis is not possible. Therefore, a more flexible field length definition of the 
boost fields by using both collimator blocks for generation of each of the two boost 
fields, implying a sequential delivery of these fields, is impossible. The leaves of the 
multilcaf collimator of the MM50 have a maximum overtravel of 14 em, allowing more 
flexibility in the choice of I by rotating the collimator 90° prior to the delivery of the 
boost fields. These fields should then be delivered separately using the leaves for the 
definition of I and the blocks for definition of the width of the boost field. Because of 
the good results obtained with the relatively simple technique described above we did 
not study this more complex and time-consuming technique with collimator rotation. 
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3.2.2 Evaluation of the 1M technique based on 3D treatment planning 
To assess the effectiveness of the proposed use of intensity modulated X-ray beams, 
3D treatment plans have been made for ten prostate cancer patients with PTV lengths 
ranging from 7.5 to 12 cm using the Cadplan 3D planning system manufactured by 
Varian-Dosetek [6,139,140]. For each patient three plans have been compared: A) our 
standard technique with field margins in the superior-infcrior direction of 1.5 cm, B) 
the same technique but with field margins in superior-inferior direction of only 0.7 cm, 
and C) the IM tecllllique described in the previous section, based on field margins of 
0.7 cm and application of superior and inferior boost fields. 
For all patients, CT -slices with 0.5 cm spacing were available. To improve the spatial 
resolution for penumbra analyses in the superior-inferior direction, dose calculations 
were also performed for CT -slices generated by interpolation at intermediate positions; 
within each slice a grid size of 0.5 cm was used for the dose calculations. 
For treatment planning, the gross tumor volume (OTV) [62] - i.e. prostate (for patients 
1,2 and 6) or prostate + vesiculae seminalis (other patients) as delineated on CT-slices 
by the physician - was expanded in 3D [143,144] with a margin of 1.5 cm to render the 
PTV. For the bladder and the rectum the outer surfaces were contoured. The rectum 
was contoured fl'Om 2.5 cm inferior of the PTV to 2.5 cm superior of the PTV. 
Treatment plans were designed and evaluated using 3-dimcnsional planning tools such 
as beam1s eye view (BEV), dose distributions in coronal and sagittal planes nnd dose 
volume histograms of the PTV, the rectum and the bladder. Dose profiles along the 
superior-inferior axis through the isocenter have been used to quantify the superior and 
inferior reduction in distance between the 50 % and 95 % isodose surfaces, resulting 
from the applied boost fields in plan C. For each patient, the percentual changes 
between the IM plan and the standard plan in rectal and bladder volumes receiving a 
dose higher than 80% of the isocenter dose and in the maximum rectal and bladder 
doses have been quantified. 
3.2.3 Accuracy of dose calculations 
The high accuracy of the implemented dose calculation algorithms in Cadplan (version 
2.62) for photon fields larger than 4x4 cm' has been demonstrated [6,139,140]. To 
assess the accuracy of these algorithms for the 25 MV narrow boost fields, calculated 
relative dose distributions for off-axis fields as small as I.lx5.0 cm' have been com-
pared with distributions measured in a water phantom (RFA-300, manufactured by 
Scanditronix Medical AB) using a linear detector array consisting of II p-type diodes, 
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and with distributions measured with film, irradiated horizontally in a polystyrene 
phantom at a depth of 3.5 cm (the depth of maximum dose for the 25 MV photon 
beam). In the latter case, measurcd optical densities were converted into doses by 
applying a sensitometric curve determined for the beam axis of a IOxlO cm' field using 
the same set-up. All measurements were performed with a source to surface distance of 
100 cm. 
Absolute dose calculations of Cadplan were checked by comparison with dose 
measurements performed at a depth of 3.5 cm in the center of the narrow boost fields, 
using a semiconductor detector (manufactured by Scanditronix Medical AB). The 
readings of the semiconductor were converted to dose by applying a conversion factor 
measured at the same depth on the beam axis of a lOx 10 cm' field. Required phantom 
scatter factors, needed to improve the accuracy of the monitor unit calculations of 
Cadplan for the small boost fields, were determined from measurements of the head-
scatter factor and the total-scatter factor [156] for square fields of 4x4 down to 1x1 
cm'. All scatter factors were determined relative to the IOxlO cm' field. The head-
scatter factors were measured with an RK-chamber vertically positioned in a brass 
buildup cap with sidewalls of 2 gcm" [89,180] and a front-wall of 10 gcm". In order to 
ensure the 1x1 cm' radiation field to fully encompass the used buildup cap, the source 
to surface distance was extended from 100 to 120 cm. Measurements of the tota1-
scatter factors were performed in water at a depth of 10 cm [141] using a 
semiconductor detector; a source to surface distance of 100 cm was used. 
3.2.4 Implementation on the MM50 Racetrack Microtron 
As described in section 1.3, the MM50 can be operated in a fully computer-controlled 
multi-segment treatment mode. In this mode the technicians set-up only the lirst 
segment (field) of a patient treatment. All parameters of the next segments, like the 
gantry and collimator angles, couch positions, field shapes, beam energies and monitor 
units, are set-up and verified by the treatment computer. In between segments, the 
technicians do not enter the treatment room. Segments without dose (,dummy' 
segments) can be used to temporarily displace the treatment table in order to increase 
the distance between the patient and the treatment head before rotating the gantry. For 
treatment of prostate cancer patients we lise two 'dummy' segments. The extra time 
needed for delivery of the boost fields has been assessed using the fully computer-
controlled multi-segment treatment mode. 
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3.3 Results and discussion 
3.3.1 Evaluation of the 1M technique based on 3D treatment planning 
A Dose profiles along the superior-inferior axis 
For all patients, the dose profiles along the superior-inferior axis through the isocenter 
have been analyzed for plans A and C (see above) to assess the superior and inferior 
reduction in distance between the 50% and 95 % isodose surfaces resulting from the 
application of the boost fields. As an example, figure 3.2a shows the dose protlles for 
patient 3; figure 3.2b shows the dose distributions of the superior and inferior boost 
fields that are added to plan B, yielding plan C. The average reduction in the superior 
and inferior 50-95% penumbra widths due to the application of boost fields is 0.66 ± 
0.25 cm (l standard deviation) for all patients. 
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Figure 3.2 a Dose profiles ill superior-inferior direction through the isocenterfor patient 
3 ill tllis study. Curl'e A: superior-inferiorfield margins of 1.5 cm; Cllrl'e B: 
superior-illferior field margins of 0.7 cm; Cllrl'e C: superior-inferior field 
margins of 0.7 em alld boost field .... 011 tile superior alld inferior ends of the 
pn'. 
b Addition afthe boost profiles to CIIIl'e B yields Cllive C afthe lM techlliqlle. 
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B Dose distribution in the PTV 
For the 3-dimensional PTV, minimum doses and dose homogeneities, expressed as the 
standard deviation (a) of the observed deviations from the average dose, are 
summarized in table 3.2. Each dose distribution lVas normalized to 100% iu the 
isocenter. The data show that for nine of the ten patients a field margin in superior-
inferior direction as large as I.S em (plan A) lVas not enough to fully comply with the 
ICRU-SO recommendations for dose homogeneity in the PTV [62], i.e. in some parts of 
the PTV (situated in the superior and inferior ends) the dose is still somewhat less than 
9S%. With field margins in superior-inferior direction of 0.7 cm and no boost fields 
(plan B), the minimum dose in the PTV lVas on average 88.4 % for the 10 patients; for 
patient 4 the minimum PTV dose was only 86.S %. Using superior-inferior field 
margins of 0.7 cm in combination with boost fields (plan C, the 1M teclmique) yielded 
a minimum PTV dose of 9S% for all patients. This technique also yielded the best dose 
homogeneity, i.e. the smallest values for a. 
Table 3.2 Minimum dose (Dillin) and dose homogeneity (oJ in the PTV for the three 
treatment plans described ill sectioll 3.2.2. 
plan A B C 
field margin field margi n field margin 
I.S cm 0.7 cm 0.7cm 
+ boost fields 
patient Dmin (%) a(%) On'" (%) a(%) Dmin(%) a(%) 
I 9S.6 1.3 88.S 2.4 9S.6 l.l 
2 93.6 1.3 88.S 2.1 95.0 1.2 
3 94.S 1.9 89.S 2.7 9S.0 1.8 
4 92.6 1.8 86.S 2.S 9S.0 I.S 
S 94.S 1.3 87.6 2.0 9S.6 1.2 
6 93.6 1.4 89.S 2.2 9S.6 1.2 
7 93.S 1.6 86.7 2.1 9S.6 l.l 
8 94.S 1.4 89.6 1.9 95.6 1.2 
9 94.5 1.3 88.6 1.9 9S.6 1.2 
10 93.6 1.3 89.S 1.7 9S.6 1.3 
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C Dose distribution within rectum and bladder 
As demonstrated in table 3.2 and explained in subsection B, our standard technique 
and the 1M technique allow, respectively, near and full compliance with the dose 
homogeneity recommendations mentioned in the ICRU-50 report [62]. Due to the 
reduction of 1.6 cm in field length for the 1M technique relative to the standard 
technique (see section 3.2.1), reductions in rectal and bladder volumes in the high dose 
area could be expected for the former technique. In table 3.3, observed percentual 
decreases in the rectal and bladder volumes that receive a dose higher than 80 % of the 
isocenter dose are presented. For both the rectum and the bladder, the data show a large 
variation in the observed high dose volume reductions, strongly depending on the 
position and the shape of these critical organs relative to the most superior and inferior 
parts of the radiation fields. 
Table 3.3 Differences between Ollr standard technique alld the flv! technique with 
respect to recfal tllld bladder volumes receiving a dose of more than 80% 
(L1 V) and to the maximum dose delivered /0 these tissues (dDm(t{). Positive 
Ilumbers paim at reduced values for the Il\l[ technique. 
rectum bladder 
patient LlV (%) LlDnm (%) Ll V (%) LlD",>< (%) 
4.5 -0.4 15.6 -0.4 
2 n.3 -2.2 11.9 -3.0 
3 2.5 0.1 14.7 0.3 
4 4.1 -0.3 -0.2 -0.6 
5 0.1 0.3 1.1 0.6 
6 6.6 0.3 0.6 0.3 
7 2.3 -1.0 9.0 0.2 
8 3.1 0.3 0.5 0.3 
9 7.8 0.1 0.4 0.3 
10 8.1 -0.4 -0.9 0.5 
As explained in section 3.2.1, attention has been paid to avoid increases in the 
maximum rectal and bladder doses due to the application of the boost fields. Table 3.3 
shows that the differences in maximum rectal and bladder doses between the 1M 
technique and the standard technique are small (<1 % of the isocenter dose for nine of 
the ten patients). The observed increases in maximum doses for the 1M technique for 
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patient 2 (2.2 % in the rectum and 3.0% in the bladder) and the increase of I % in 
maximum rectal dose for patient 7 are due to the relatively large superior-inferior 
length of the applied boost fields (1.6 cm) for these patients (see table 3.1). For both 
patients the increased maximum doses occurred in one or two CT-sHces adjacent to the 
most superior or the most inferior CT-slice containing PTV (slice distance 0.25 cm). 
By choosing boost fields with a length of 1.0 cm instead of 1.6 cm for these patients. 
increased maximum rectal and bladder doses could be avoided. However, as a 
consequence the calculated minimum PTV dose went down to 94.5% for both patients. 
3.3.2 Accuracy of dose calculations 
Dose calculations of the Cadplan planning system for the narrow boost fields have 
been extensively verified by comparison with measurements. The field sizes that were 
studied ranged from I.lx5.0 em' up to 1.6x 10 cm'; the fields were positioned off-axis 
at distances of 3.2 to 6.1 cm from the isocenter. As all example, measured and 
calculated dose distributions for boost fields of 1.2x5.0 cm' and 1.2xlO cm'. positioned 
at an off-axis distance of 4.4 cm, are depicted in figure 3.3. The measurements and 
calculations have been normalized to 100% at a depth of 3.5 cm. For all cases. 
measured and calculated relative dose distributions agreed within 2% or 0.2 em. 
Initially, the Cadplan planning system calculated too high absolute doses (up to 16%) 
in the normalization point of the boost fields. The largest deviations were observed for 
boost l1elds with the smallest lengths. To a very large extent, this discrepancy was 
caused by the table of phantom scatter factors used in the Cadplan system. For fields 
larger than 4x4 cm', this table is based on data presented by Storchi and van Gasteren 
[141]. For smaller l1elds, the values in the table were obtained by a linear extrapolation. 
Based on measurements of head-scatter factors and total-scatter factors, we determined 
phantom scatter factors for square l1elds down to Ixl cm'. In figure 3.4, the results are 
depicted and compared with the original Cadplan table. For the larger fields, the 
Cadplan data agree very well with the measurements. However, serious deviations 
occur for fields smaller than 4x4 cm'. After modil1cation of the Cadplan phantom 
scatter table according to our measurements measured and calculated absolute doses 
for the boost fields generally agreed within 2%. The applied boost fields have a small 
weight (see subsection B). Therefore, the achieved accuracy of the dose calculations 
for boost fields is certainly adequate. 
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3.3.3 Implementation on the MM50 Racetrack Microtron 
For all ten patients, the increase in treatment time due to delivery of the boost fields has 
been assessed by simulation of the treatments using the fully computer-controlled 
multi-segment treatment mode. For most patients, the observed extra time for delivery 
of the boost fields was about one minute. For patients 4, Sand 7 the two boost fields in 
the left lateral oblique field were delivered sequentially (with different weights) in 
order to avoid an increase in the maximum dose delivered to the bladder andlor the 
rectum as much as possible (see also section 3.2.1). For these patients the extra time 
was about 1.S minute. 
Most of the extra time needed for delivery of the boost fields is used by the MMSO 
computer for verification of the setup. A modification of the control software of the 
MMSO, which is being developed by the manufacturer, will allow a significant 
reduction of this overhead time. 
3.4 Summary and conclusions 
In axial, co-planar treatments with multiple fields, often large field margins are needed 
for delinition of the superior and inferior field borders in order to avoid underdosages 
in the superior and inferior ends of the PTV. We have investigated the use of intensity 
modulated beams, generated with a multileaf collimator, to allow rcduction of these 
field margins while fulfilling the ICRU-SO recOlmnendations for dosc homogeneity. 
The intensity modulated beams consist of narrow, low weight boost fields 
superimposed on the superior and inferior ends of treatment lields that enclose a BEV-
projection of the PTV with well-defined, narrow field margins. 
For ten prostate cancer patients, computer planning studies have shown that due to the 
proposed application of the intensity modulated lields the field length can be reduced 
by 1.6 cm, usually resulting in significant reductions in rectal andlor bladder volumes 
receiving a high dosc. No diffcrences were observed between patients planned to the 
prostate only or to the prostate and seminal vesicles. The accuracy of the Cadplan 
planning system for calculation of relative dose distributions for the narrow boost fields 
is within 2% or 0.2 cm. After a small modification in the Cadplan system, calculated 
absolute doses of the boost fields at the depth of maximum dose generally agreed 
within 2% with measurements. 
Using the fully computer-controlled multi-segment treatment mode of the MMSO 
Racetrack Microtron, the application of intensity modulated beams would have led to 
an increase in treatment time of 1.5 minute maximum. 
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In this study we have focused on prostate cancer patients treated with our three-field 
technique. However, we have observed that introduction of boost fields in the often-
applied four field box- and six field techniques can also yielcl significant recluctions in 
field length. Improved dose distributions have also been achieved for a cervix cancer 
patient. In the next chapter the benefits of the proposed application of boost fields will 
be demonstrated for the treatment of lung cancer patients. 
In the meantime, the technique described in this chapter is used routinely in our clinic 
for treatment of prostate cancer patients. 
Chapter 4 
Beam intensity modulation for penumbra enhancement 
in the treatment of lung cancer 
Adopted from the original article by MLP Dirkx, M Essers, JR van S6rnsen de Koste, 
S Senan and BJM Heijmen, published in lilt. J. Radiat. Ollcol. Bioi. Ph),s. 44: 449-454, 
1999. 
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4.1 Introduction 
Presently, the outcome after radiotherapy alone in patients treated for non-small cell 
lung cancer is poor, as evidenced by pathological complete remission rates of only 
around 20% after doses of 65 Gy [2]. Whilst radiation dose escalation is expected to 
improvc local control [31,43), delivery of higher doses is, especially in advanced (stage 
III) tUlllors, often limited by severe complications such as radiation pneumonitis. 
despite the use of 3D treatment planning techniques [53]. Other approaches to improve 
local control rates include altered fractionation schemes and concomitant chemo-
radiotherapy, both of which are complicated by severe oesophagi tis. Continuous 
hyperfractionated, accelerated radiotherapy improved survival over conventional 
radiotherapy [131] but was accompanied by a higher incidence of severe oesophagitis 
(19% vs. 3%). With hyperfractionated radiotherapy, the likelihood of severe 
oesophagitis has been shown to correlate with the length of the oesophagus, which is 
irradiated [74]. Whilst a survival advantage was scen for patients treated with 
radiotherapy and daily cisplatin [132], the administration of active new agents such as 
paclitaxel, gcmcitabine and topotecan during radiotherapy has resulted in dose-limiting 
acute oesophagitis [26,52,54,83]. Consequently, all approaches aiming to improve the 
results of radiotherapy in non-small cell lung cancer will benefit from steps to limit the 
volume of irradiated normal tissue. 
As a prelude to a future dose escalation study for treatment of patients with a stage III 
non-small cell lung cancer, a phase II trial of induction chemotherapy, followed by 
'involved-field' radiotherapy was recently activated at the Daniel den Hoed Cancer 
Center. During the radiotherapy treatment, a dose of 70 Gy is delivered in daily 
fractions of 2 Gy to a planning target volume (PTV), which includes only the primary 
tumor, enlarged mediastinal lymph nodes with a short axis diameter exceeding 1 cm, 
and a 3D margin for geometrical uncertainties. As generally known the dose 
calculation algorithms in most treatment planning systems are less accurate in lung 
tissue than in other soft tissues, especially at higher energies, due to the influence of 
reduced electron density on secondary electron transport [45,75]. To minimize this 
problem the patients are treated at the MM50 Racetrack Microtron with the lowest 
photon beam energy. The quality index of this beam, defined as the ratio of the dose in 
water measured at isocenter for a 10 x 10 cm2 t1eld at depths of 20 and 10 em 
respectively, equals 0.704 and its percentage depth dose curve is similar to a 7 MV 
photon beam according to British JOllrnal of Radiology, supplement 25 [\8]. An 
isocentric irradiation technique is used with one anterior oblique, one posterior oblique 
and one lateral oblique field (see figure 4.1). For each patient, the beam orientations 
are optimized to minimize the dose delivery to surrounding healthy tissues, i.e. the 
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Figllre 4.1 Central transversal CT-slice of patient 4 showing tile three treatmelll fields. 
contra- and ipsilateral lungs, the spinal cord and the oesophagus. The beams are 
shaped with a multileaf collimator lIsing the beam's eye view projection of the PTV. 
The fields may be partly delivered with a 60° motor wedge inserted. The intention is to 
comply with the ICRU-50 recommendations for dose homogeneity (62): the dose in 
the 3D PTV is aimed to be within -5 and +7% of the dose in the ICRU-point, i.e. the 
isocenter. To account for beam penumbrae, beam apertures are defined by adding a 
field margin of 0.8 cm to the lateral, the anterior and the posterior beam's eye view 
projections of the PTV. Depending on the calculated dose distribution in the superior 
and inferior ends of the PTV, a margin of at least 1.5 cm is used for definition of the 
superior and inferior field borders to accouut for the dose reduction due to the overlap 
of penumbrae of all involved treatment fields [25,39). However, even with a field 
margin of 2.5 cm, the 95% isodose is not yet completely encompassing the most 
superior and inferior parts of the PTV for some patients. An identical treatment 
technique is also used for stage I lung patients who are treated without elective nodal 
irradiation. 
In the previous chapter, we described a technique using beam intensity modulation 
(BIM) for penumbra enhancement, which allows a reduction of the large superior and 
inferior field margins around the PTV. By applying this technique for treatment of 
prostate cancer patients, the superior-inferior field lengths could be reduced with 1.6 
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cm compared to the standard technique, while complying with the ICRU-50 dose 
homogeneity criteria for the PTV, generally yielding smaller volumes of rectum and 
bladder in the high dose region. 
In this chapter, the application of this BIM technique is evaluated for six consecutive 
stage III patients who participated in the above-described phase II study and for six 
consecutive stage I patients. Using 3D treatment plans, the potential benefits of the 
technique are demonstrated. Compared to the standard teclmique, defined as the 
previously described technique with fixed field margins in snperior and inferior 
direction of 1.5 cm, the possible dose escalation for the BIM treatment has been 
estimated, while keeping the calculated risk of pneumonitis constant. 
4.2 Methods and materials 
4.2.1 The 81M technique 
With respect to the standard technique described in the introduction, only two 
modifications were made: 1) for all three fields the field margin for definition of the 
superior and inferior field borders was fixed at 0.8 cm instead of 1.5 cm, and 2) for one 
of the treatment fields used in the standard technique the in-field fluence profile was 
modified by superimposing narrow, low-weight boost fields on the superior and 
b 
Figllre 4.2 Posterior field Jor patient 4 in this stlldy Jor the standard techniqlle (a) and 
the BIM technique (b). For the BIM technique, boost fields (shaded areas) 
are superimposed 011 the superior alld illferior parts of the treatment jiehl 
and the total field length is redllced by 1.4 cm. The dashed lines sholl' the 
field length reduction with respect to the field shown ill a. 
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inferior ends (see figure 4.2). Boost fields were only applied in one beam in order to 
minimize the increase in treatment time in a future clinical application of the BIM 
technique. The selection of this beam was determined by the position of the target 
relative to the normal structures, especially aiming to avoid increased dose delivery to 
the contralateral lung and the spinal cord. For all patients this aim could be achieved by 
never adding the boost fields to the lateral oblique field and by avoiding beam 
orientations showing the spinal cord in the superior and inferior ends of their beam's 
eye view. When both the anterior and the posterior oblique fields fulfilled this last 
requirement, the beam orientation for the boost fields was determined by the shortest 
pathlength tln'ough healthy lung tissue from the skin to the target. 
Generally, the superior and inferior boost fields were delivered simultaneously by 
closing leaf pairs in the central part of the beam, while keeping the position of the 
collimator blocks fixed. The superior-inferior length I of the applied boost fields was 
related to the field length L as defined by the collimator blocks by: 
1= (L-II·w)12 (4.1) 
with II the number of central leaf pairs that are closed during delivery of the boost 
fields and II' the leaf width (1.25 em at the MM50 Racetrack Microtron). L is the sum 
of the superior-inferior PTV length and the applied fixed field margins of 0.8 cm. As 
we concluded from our planning study for prostate cancer patients (see previous 
chapter), the length of the boost fields should be at least 1.1 cm to avoid underdosages 
in the PTV in CT-slices situated next to the most superior and inferior slices with PTV. 
In agreement with this requirement, the smallest length I that obeys equation (4.1) was 
selected, yielding 1.1 cm S; I S; 1.6 cm. 
The weight of the boost fields was chosen such that the minimum dose in the inferior 
and the superior ends of the PTV was at least 95% of the isocenter dose. hI case 
simultaneous delivery of the boost fields yielded a minimum dose in the most superior 
or the most inferior part of the PTV that was significantly larger than 95% of the 
isocenter dose, e.g., due to the shape of the tumor or due to variations in patient 
contour in superior-inferior direction, a modified plan, based on a sequential delivery 
of the two boost fields with different weights, was considered. 
4.2.2 Evaluation of the 81M technique 
To investigate the proposed use of intensity modulated x-ray beams, 3D treatment 
plans were made for twelve lung cancer patients (see table 4.1) using the Cadplan 3D 
treatment planning system (version 2.7) manufactured by Varian-Dosetek [139,140]. 
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Table 4.1 Characteristics afthe patiellts ill this study. The volume of the healthy Illllg 
/;:';sue (columN 4) was defined as the total lung volume minus the volume of 
the G1'\!. 
patient stage volume PTV volume healthy length PTV (em) length boost 
(cc) lung tissue (ee) fields (cm) 
III 372 5895 10.0 1.4 
2 III 208 3586 6.5 1.5 
3 III 456 3847 ll.5 1.5 
4 III 305 1921 7.5 1.4 
5 III ,.477 3059 8.0 l.l 
6 III 648 2876 17.0 1.2 
7 I 44 3877 3.5 1.3 
8 I 191 5997 9.0 1.6 
9 I 372 2702 12.5 1.6 
10 I 205 3699 8.0 l.l 
II I 63 3386 5.0 1.4 
12 I 218 4377 8.0 l.l 
For each patient, three plans were compared: A) the standard plan (field margins in the 
superior-inferior direction of 1.5 cm), B) a modified standard plan (field margins in the 
superior-inferior direction of only 0.8 em), and C) the BIM plan (field margins of 0.8 
em and the application of superior and inferior boost fields in one of the treatment 
fields, as described in the previous subsection). 
For all patients, CT-slices with 0.5 cm spacing were available. For treatment planning, 
the gross tumor volume (GTV) [62], the ipsilateral lung, the contralateral lung, the 
spinal cord and the oesophagus were contoured on each CT -slice. To account for the 
set-up variability and motion due to respiration and heartbeat, a margin to the GTV was 
automatically added in 3D [143,144], rendering the PTV. In all directions the applied 
margin was 1 em, except for tumors located adjacent to the diaphragm for which a 
margin of 2 em was used in superior and inferior directions. 
In the Cadplan system the generalized Batho method was used to account for lung 
inhomogeneity effects. Each plan was normalized to 100% at the isocenter, where a 
total dose of 70 Gy was prescribed. All plans were evaluated using 3-dimensional 
planning tools such as dose volume histograms for the PTV, the healthy lung tissue 
(i.e. the contralateral lung plus the ipsilateral lung minus the GTV), the oesophagus 
and the spinal cord. 
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The dose distribution in the healthy lung tissue was evaluated using the following 
parameters: (i) the average normalized total dose (NTD), calculated using an alp ratio 
of 3 Gy [82,84,85], (ii) the relative volume receiving an NTD of more than 20 Gy [53], 
and (iii) the calculated normal tissue complication probability (NTCP), based on the 
Lyman model [99], and the DVH-reduction algorithm described by Kutcher et at [81], 
using the following parameters: TDso=28.0 Gy, n=0.87 and m=0.18 [107]. In all 
analyses the two lungs minus the GTV were considered as one functional unit. To 
estimate the incidence of pneumonitis. two published models were used: the average 
NTD [82,85] and the calculated NTCP. For stage III patients, treated with chemo-
radiotherapy, resulting in the highest risk for severe oesophagi tis, the length of the 
oesophagus, which received a dose of more than 60 Gy was quantified [74,83]. For the 
BIM plan, possible dose escalations were estimated, keeping the average NTD or the 
calculated NTCP at the same level as in the standard plan (plan A). 
4.3 Results 
4.3.1 Dose distributions in the PTV 
Figure 4.3 shows dose distributions in the sagittal plane through the isocenter for plans 
A and C of patient 4 in this study. As a result of the application of the boost fields, the 
distance between the 50 and 95% isodose surfaces reduced by 0.8 cm both around the 
Figure 4.3 
a b 
Dose distributions ill the sagittal plane through the isocellferjor patient 4 
in this study: a) Jar the standard technique and b) Jar the BIM technique. 
Depicted are the PTV (solid line) and the 50 and 95% isodose lines. 
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superior and the inferior ends of the PTV. Moreover, while with the standard technique 
a penumbra margin of 1.5 em was not sufficient to encompass the superior end of the 
PTV with the 95% isodose surface, the BIM technique yielded a minimum dose in the 
entire PTV of 95% with a reduced field length of 1.4 cm. 
For all patients in the study, the minimum doses delivered to the superior and inferior 
ends of the PTV are summarized in table 4.2. The data show that with a field margin of 
1.5 cm the minimum dose in the most superior and inferior parts of the PTV was 
93.6% on average (range 91.2 to 95.4%) and that for only 4 of the 12 patients a 
minimum dose of 95% was obtained. With field margins of 0.8 cm and no boost fields 
(plan B), the minimum dose decreased to 89.4% on average (range 85.5 to 92.9%). 
Combining field margins of 0.8 cm with the application of boost t1elds (plan C) 
resulted in a minimum dose at the snperior and inferior ends of the PTV of 95% for all 
patients. 
Table 4.2 Millimum dose (in % of the isocellfer dose) ill the superior (llld inferior ends 
of the PTV for the three techl/iques described il/ the text. 
patient PlanA planB plan C 
field margin 1.5 cm field margin 0.8 cm field margin 0.8 cm 
+ boost fields 
1 91.2 87.8 95.0 
2 92.9 88.5 95.2 
3 94.5 85.5 95.1 
4 92.6 89.1 95.2 
5 92.6 88.8 95.0 
6 95.0 89.3 95.2 
7 95.4 92.5 95.4 
8 93.4 90.3 95.0 
9 91.5 86.8 95.2 
10 95.0 91.9 95.0 
II 95.4 92.9 95.5 
12 93.6 89.4 95.0 
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4.3.2 Dose distributions in normal tissues 
For all patients in this study, the advantages of the BIM technique for sparing the 
healthy lung tissue are summarized in table 4.3. Relative to the standm'd technique the 
patient mean of the average lung NTO reduced by 8.2% (range 1.5 to 20.6%) and the 
volume of healthy lung tissue receiving an NTO of lllore than 20 Oy reduced by 9.7% 
(range 2.2 to 23.1%). With BIM the calculated NTCP was reduced from 10.7% to 
7.6°;6 on average. 
1tib/e 4.3 Evaluation of the BIM technique (plan e) for the healthy hmg tissue using 
(i) the fraction of IlIl1g tisslie receiving (1Il NTD of more than 20 G)' (\1>20 Gy 
), Iii) NTDm " the average NTD, alld liii) the calculated NTCP. LlI'>20 Gy' 
ANTD,lrg and ANTep are the improvements with the BIM techllique 
compared to the standard technique (plan A - plan e). 
Patient V>20Gy(%) fl"V>200y(%) NTO"'g fl"NTO"g NTCP(%) fl"NTCP 
(Oy) (Oy) (%) 
24.8 1.7 15.4 0.6 4.8 1.8 
2 21.2 2.8 13.4 1.2 1.8 1.7 
3 24.1 1.8 15.6 0.8 4.6 1.9 
4 32.7 2.5 20.5 1.7 26.2 12.4 
5 28.4 3.2 18.0 1.7 11.7 9.4 
6 36.3 0.8 25.8 0.4 67.9 3.2 
7 16.3 4.9 9.6 2.5 0.2 0.6 
8 22.9 1.3 14.9 0.4 3.8 1.2 
9 19.3 1.7 12.2 1.2 0.8 0.7 
10 20.5 2.0 13.9 l.l 2.1 1.5 
II 13.6 3.1 8.7 1.9 0.1 0.2 
12 24.6 2.1 15.3 1.0 4.2 2.5 
For stage III tumors, the length of the oesophagus that received a dose of 60 Oy or 
more is indicated in table 4.4. Compared to the standard technique the length of the 
oesophagus in the high dose region was reduced by 0.7 cm (range 0 to 1.3 cm) on 
average by application of the BIM technique. For the only patient where no 
improvement was observed, only 2.2 cm of the oesophagus received a dose higher than 
600y. 
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Length L of the oesophagus receiving a dose of 60 Gy or 1II0re for the RIM 
technique for the stage III patients. L1L indicates the reduced length in the 
high dose region compared to the standard techuique. 
Patient L (cm) i'lL (cm) 
1 10.7 0.6 
2 7.1 1.3 
3 2.2 0.0 
4 5.5 0.6 
5 8.9 1.3 
6 10.0 0.4 
As a result of the penumbra enhancement, a dose escalation would be possible with the 
BIM technique for all patients, whilst keeping the average NTD or the calculated 
NTCP at the same level as in the standard plan (see figure 4.4). Based on equal 
NTCPs, the patient mean of the allowed dose escalation was 5.7 Gy (range 1.1 to 16.0 
Gy) with the BIM technique. Based on equal mean NTDs, the possible dose escalation 
would even be slightly higher, i.e. 6.5 Gy on average (range 1.1 to 18.2 Gy). With 
these dose escalations, the maximum spinal cord dose would be between 1.9 Gyand 
41.6 Gy for the patients in this stndy. 
Figure 4.4 
20 
15 
>: 
!:!- 10 
Q 
<l 
5 
o 
mJbased onNTDl 
Dbasedon_~ 
2 3 4 5 6 7 
patient 
u , 10 ~ I 
" 
8 9 10 11 12 
Estimated possible dose escalations with the BlA1 technique, based all 
eqllal average NTDs and equal NTCPs as for the standard technique. 
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4.4 Conclusions and discussion 
A treatment planning study for twelve patients with lung cancer has shown that the 
proposed technique for static beam intensity modulation with an MLC allows a 
reduction in the field lengths by 1.4 cm, yielding a reduced dose delivery to the 
surrounding normal tissues. All parameters used to evaluate dose distributions in the 
healthy lung tissue point at a potential for dose escalation (6-7 Gyon average) with the 
BIM technique, without increasing the incidence of pneumonitis. For two patients a 
dose escalation of more than 15 Gy would even be possible. In an on-going dose 
escalation study, patients are stratified according to the calculated effective lung 
volume V,ft' [129] which is directly correlated to the calculated NTCP in our study, 
because the same parameters (m, n, TD,D) are used. In our clinic the BIM technique 
will fist be introduced to reduce the observed normal tissue complication rates. In a 
second phase, dose escalation will be considered as one of the options to intensify the 
treatment of lung cancer patients. 
It is well known that the dose calculation algorithms in most treatment planning 
systems are less accurate in lung tissue than in other soft tissues, especially at higher 
energies, due to the int1uence of reduced electron density on secondary electron 
transport [45,75]. Also the Batho algorithm in the Cadplan treatment planning system 
is of limited accuracy for dose calculations in lung tissue. This was the main reason for 
selecting a low beam energy for this study. Before implementing the BIM technique for 
lung patients in clinical practice we have performed an extensive dosimetric study to 
assess the accuracy of the calculated dose distributions by comparison with dose 
distributions measured in anthropomorphic phantoms. This dosimetric study, described 
in the next chapter, yielded recommendations to further optimize the weight and width 
of the applied boost fields used in the proposed BIM technique to compensate also for 
the increased lateral secondary electron transport in lung tissue around the superior and 
inferior ends of the PTV, which especially in these areas might have a significant 
int1uence on the delivered dose distribution due to the overlapping penumbrae of all 
treatment fields. 
In all co-planar irradiation techniques, the penumbrae of the superior and inferior field 
edges of all treatment fields overlap, yielding broad overall penumbrae in these regions 
[25,39]. Therefore, the rcduced dose delivery to critical structures with the proposed 
BIM technique, related to the decreased superior-inferior field lengths, is not typical for 
the treatment technique applied in our clinic; improved treatment plans are to be 
expected for all co-planar teclmiques. The BIM technique could also be advantageous 
in the treatment of small cell lung cancer, where early concomitant chemo-radiotherapy 
has shown to result in improved survival [115], albeit with increased normal tissue 
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toxicity. BlM is already routinely applied in our clinic for treatment of prostate cancer 
patients and head and neck cancer patients. The extra time needed for set-up and 
delivelY of the boost fields is usually less than one minute. Treatment plans for the 
BIM technique are easily obtained by 'forward' treatment planning; sophisticated 
computer optimization algorithms are not required. 
Chapter 5 
Beam intensity modulation for penumbra enhancement and field 
length reduction in lung cancer treatments; a dosimetric study 
Adopted from the original article by MLP Dirkx and BJM Heijmen, published in 
Radio/her. Ollcol. 56: 181-188,2000. 
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5.1 Introduction 
In all axial co-planar irradiation techniques, there is an overlap of the penumbrae of all 
treatment fields around the superior and inferior ends of a plmming target volume 
(PTV), yielding a relatively large distance between the overall 95 and 50% isodose 
surfaces in these regions [25,39]. Around field corners, the dose fall-off is even 
shallower due to lateral electronic disequilibrium in both longitudinal and lateral 
directions. As a result, in superior and inferior direction large field margins should be 
added to a beam's eye view projection of the PTV to comply with ICRU-50 
recommendations for dose homogeneity [62]: a dose in the 3D PTV within -5 and +7% 
of the dose in the ICRU-point, i.e. the isocenter. While in the three-field technique used 
in our clinic for treatment of prostate cancer patients field margins of 0.5 to 0.8 cm are 
adequate for definition of the lateral, anterior and posterior field borders, a margin of 
1.5 cm for definition of the superior and inferior field borders still yields underdosages 
in the superior and inferior ends of the PTV for nearly all patients [39]. Because of the 
major impact of beam penumbrae on field margins required in superior and inferior 
directions, we developed an easy and practical technique for penumbra enhancement 
around the superior and inferior ends of a PTV and field length reduction using static 
beam intensity modulation (BlM) with a multileaf collimator (see chapter 3). The 
applied intensity modulated x-ray beams consist of narrow, low-weight boost fields, 
superimposed on the superior and inferior ends of treatment fields that encompass the 
beam1s-eyc-vicw projection of the PTV with narrow field margins in superior and 
inferior directions. We demonstrated that application of this technique allows the use of 
superior and inferior field margins of only 0.7 cm for prostate cancer patients, yielding 
a Held length reduction of 1.6 cm for all fields compared to our (previous) standard 
technique. Using ElM, the conformity of the dose distribution to the tumor volume is 
improved, generally reducing the volumes of rectum and bladder in the high dose 
region. CUll'ently, this BIM technique is routinely applied in our clinic for treatment of 
prostate cancer patients and head and neck cancer patients. 
The results of a treatment planning study for twelve lung cancer patients treated with 
'involved Held radiotherapy', which were described in the previous chapter, 
demonstrate that a field length reduction of 1.4 cm, combined with penumbra 
enhancement by applying the described ElM technique, may result in reduced dose 
delivery to critical structures in co-planar lung treatments as well. Using the average 
normalized total dose (NTD) in the healthy lung tissue and the calculated normal tissue 
complication probability (NTCP) as estimates for the risk of radiation pneumonitis 
[82,107], it was concluded that a dose escalation of 6 Gy on average would be possible 
with BlM, without increasing the incidence of radiation pneumonitis. For two patients 
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in the study the potential for dose escalation even exceeded IS Gy. 
In an experimental study Brugmans ef al [19] investigated some fundamental 
dosimetrical aspects of ElM in lung cancer treatments for a set of idealized square 
fields. They concluded that the use of an 8 MV photon beam is more suitable than the 
use of an 18 MV beam, due to the increased lateral secondary electron transport in lung 
tissue at higher energies, requiring larger field margins to get the same target coverage. 
Because most commercially available treatment planning systems are not capable of 
predicting penumbra broadening in soft tissues accurately, they stated that patient-
specific measurements would generally be required for clinical application of BIM. 
Based on the prOlnising results of our treatment plmming study, we decided to start an 
extensive dosimetric study on the use of BIM for superior-inferior field length 
reduction in lung cancer treatments in order to (i) adapt our BIM technique to properly 
account for increased lateral secondary electron transport, (ii) compare BIM dose 
distributions in lung material with dose distributions of standard trcatment fields, and 
(iii) derive practicalmles to use our treatment planning system for the design of BIM 
treatment plans for lung cancer patients. To minimize the increase of lateral secondary 
electron transport in lung tissue, the investigations were performed for low-energy 
photon beams [19,45,75], which are also routinely used in our clinic for treatment of 
lung cancer patients. 
5.2 Material and methods 
5.2.1 The 81M technique 
For the 'standard' technique, treatment fields were designed by adding field margins of 
1.5 cm around the beam's-eye-view projection of the PTV. For the BIM technique, two 
modifications were made: (i) the field margins in the superior and inferior direction 
were reduced to 0.8 cm and (ii) the in-field fiuence profile was modified by 
superimposing narrow, low-weight boost fields on the superior and inferior ends of the 
treatment field (see figure 5.1), as explained in the introduction. The superior and 
inferior boost fields were delivered simultaneously by closing leaf pairs in the central 
part of the beam wlnle keeping the position of the collimator blocks fixed. The 
superior-inferior length I of the applied boost fields (see figure 5.1) was related to the 
Held length L as defined by the collimator blocks by 
1= (L - II'lV)/2 (5.1 ) 
with /I the number of central leaf pairs that are closed during delivery of the boost 
fields and II' the leaf width (1.25 cm at the MM50 Racetrack Microtron and 1 cm at the 
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Figure 5.1 
a b 
-----
L 
Beam's eye view projections of a treahnellf field used ill the 'standard' 
techllique (a) alld the B1M techllique (b). For the BIM techllique, boost 
fields with length I (shaded areas) are superimposed 011 the superior and 
illferior ends of the PTV alld the total field lellgth L is reduced by 1.4 CIII. 
The dashed lilies ill (b) illustrate the field size reductioll with respect to the 
field sholl'lI ill (a). 
Siemens KD2). L equals the superior-inferior PTV length plus two times the applied 
field margin of 0.8 cm. 
In our planning study for prostate cancer patients, described in chapter 3, it was 
concluded that the length of the boost fields should be at least 1.1 cm to avoid 
underdosages in the PTV in CT -slices situated next to the most superior and inferior 
slices with PTV. Accounting for this requirement, the smallest length I that obeys 
equation 5.1 was selected, yielding 1.1 cm"; I ,,; 1.6 cm. The weight of the boost fields 
was chosen such that the minimum dose in the inferior and the superior ends of the 
PTV was at least 95% of the isocenter dose. Similar values for the length and the 
weight of the boost fields were found in our treatlllellt plallnillg study for lung cancer 
patients, described in chapter 4. In the present study, dose distributions lIleasured in 
lung equivalent material were used to experimentally optimize the lengths and the 
weights of the boost fields to account for the increased lateral secondary electron 
transport in lung tissue. 
5.2.2 Dosimetric measurements 
Film dosimetry was performed in three phantoms. The first phantom (,water 
geometry') consisted of only polystyrene, the second one ('lung geometry') consisted 
of slabs of polystyrene (in total 5 cm thick), lung equivalent material (Ganunex, p~0.3 
gcnl,3, in total 12.5 cm thick) and again polystyrene (in total 5 em thick). The third 
phantom ('tumor geometry') consisted of 3 cm polystyrene, 10 cm lung equivalent 
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material and again 3 cm polystyrene. A tumor volume (GTV), composed of 
polystyrene, with a cylindrical cross section with axes of 6 and 10 cm and a thickness 
of 5 cm was situated in the lung material (sec figure 5.2). For this phantom a PTV was 
defined by expauding the GTV in 3D [143,144] with a margin of I cm to account for 
set-up inaccuracies and internal organ motion due to breathing, as encountered in 
clinical practice [42]. 
Figure 5.2 
, 
·B 
sagittal cross section frontal cross section 
_ polystyrene D lung 
Sagittal (lnd frolltal cross sectiolls through the center of the GTV in the 
'nil/lOr geolllelly' (alollg fille A-B). The PTl~ illdicated by a dashed fille, 
was defined by expanding the GN il1 3D with a margin of 1 em. 
The fihn measurements were performed for the 6 MV photon beam of a Siemens KD2 
and for the 10 MV beam of an MM50 Racetrack Microtron (Scanditronix Medical 
AB). The 6 MV beam has a quality index, defined as the ratio of the dose in water 
measured at the isocenter for a 10 x 10 cm2 field at depths of 20 and 10 cm 
respectively, equal to 0.675. The applied 10 MV photon beam of the Racetrack 
Microtron has a quality index of 0.704 and a percentage depth dose curve similar to a 7 
MV photon beam according to British Joumal of Radiology, Supplement 25 [18]. 
Films (Kodak XV) were positioned in the phantoms perpendicular to the beam axis at 
depths ranging from 7.5 to 15 cm. Measured optical densities were converted into 
doses by applying a sensitometric curve determined in polystyrene at the depth of dose 
maximum in a IOxlO cm2 field using a focus to surface distance of 100 cm. 20 dose 
distributions for 'standard' flat t1elds were compared with 1.4 cm shorter, intensity 
modulated t1elds in which boosts fields were superimposed on the most superior and 
most inferior parts of a flat field for penumbra enhancement. All dose distributions 
were normalized to 100% in the center of the treatment field. 
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5.2.3 Treatment planning 
For both the standard fields and the intensity modulated fields, 20 dose distributions 
were calculated using our Cadplan 3D treatment planning system (version 2.7.9) 
manufactured by Varian-Oosetek [139,140]. The generalized Batho method was used 
to account for lung inhomogeneity effects. Each plan was normalized to 100% in the 
field center. 
In Cadplan, a table of phantom scatter factors is used, based on data for square fields 
larger than 4x4 cnl, as presented by Storchi and van Gasteren [141]. For smaller fields 
the values in the table were originally obtained by linear extrapolation, but to improve 
the accuracy of the predicted dose delivered by the boost fields, these values were 
modified into the ratio of total-scatter factors measured in water and head-scatter 
factors measured in a brass mini-phantom [39]. 
5.3 Results 
5.3.1 Sensitometric curve for polystyrene and lung 
To verify that the same sensitometric curve could be used in polystyrene and in lung 
equivalent material, films were irradiated at a depth of 10 em in the water geometry or 
in the lung geometry to prescribed doses at the central axis ranging from 10 to 70 cGy 
using a lOx 10 em2 field. For both phantoms the required number of monitor units was 
calculated using our treatment planning system and the delivered dose at the central 
axis was verified by measurements with a NE 2571 ionization chamber. Prescribed 
doses and doses measured using the ionization chamber agreed within 2%, whilst the 
agreement between optical densities measured in both phantoms was within 1%. 
5.3.2 Comparison of dose distributions in polystyrene and lung for 
standard flat fields 
To demonstrate the effect of increased lateral electron transport on the beam 
penumbrae, dose distributions measured in polystyrene and in lung equivalent material 
were compared. In figure 5.3a dose profiles for the 10 MV photon beam along a central 
axis of a IOxlO cnl field are depicted. The 95-50% dose fall-off is 1.2 cm in 
polystyrene and 1.9 cm in lung. This increase in 50-95% penumbra is comparable to 
the results for 10 MV reported by Ekstrand and Barnes [45]. Figure 5.3b compares 
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Figure 5.3 a Dose profiles aloug a central axis of a 1QrlO cm2 field measured in 
polystyrene (saUd Une) alld ill lung equivalent material (dotted Iille) for 
the 10 l\tfV photon beam at a depth of 10 em lIsing a foclIs to slllfll['e 
distallce of 100 CIII. 
b Atleasured and calculated isodose distributions (soUd alld dashed Ulles 
respectively) for this lOxIa CIII' field ill polystyrelle (I~ft) alld hlllg 
eqllivalellllllaterial (right). Depicted are the 20, 50, 90 alld 95% isodose 
levels. 
measured and calculated 20 dose distributions for this IOxlO em' field in polystyrene 
and lung equivalent material. The measurements show that, due to the lateral transport 
of secondary electrons in two directions in the tleld corner, the distances between the 
95 and 50% isodose levels increase to 2.1 cm in polystyrene and even 3.7 Cill in lung. 
For the 10 MY photon beam the 90% isodose line in lung is similar to the 95% isodose 
line in polystyrene. At 0.8 cm within the tleld borders, where the most superior and 
inferior parts of the PTY are located when applying the BIM technique (see section 
5.2.1), the difference ill relative dose between polystyrene and lung equals 10%. Due to 
a lower secondary electron transport, the differences between dose protlles measured in 
polystyrene and lung are smaller for the 6 MY beam, ranging up to 5% at 0.8 cm 
within the field borders. 
Since Cadplan does not account for the increased lateral secondary electron transport in 
lung material, a dose distribution for water is predicted for both phantoms (see tlgure 
5.3b). Therefore, for lung cancer treatments, the borders of the PTY are generally 
underdosed compared with calculations by our treatment planning system. 
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5.3.3 Optimization of lengths and weights of boost fields used for 81M 
in lung 
In order to avoid uuderdosages in the superior and inferior parts of the PTV when 
applying ElM in lung cancer treatments, both the lengths I and the weights of the 
applied boost fields have to be increased with respect to the values mentioned in 
section 5,2.1, while keeping the total field length L, as defined in section 5.2.1 and 
depicted in figure 5.1, constant. In agreement with the observed differences between 
calculated and measured doses at 0.8 cm from the field border (sce previous section), 
the weight of the boost fields should be chosen such that the treatment planning system 
predicts a minimum dose of 100% of the isocenter dose at the most superior and most 
inferior ends of the PTV for 6 MV and of 105% of the isocenter dose for 10 MV. In 
reality the minimum PTV dose then just exceeds 95%. Due to the broader beam 
penumbra in lung, shown in the previous section, the lengths of the boost fields should 
be increased as well in order to avoid underdosages in CT-slices next to the most 
superior and inferior slices with PTV. Obeying equation 5.1, a length I of 1.6 or 1.8 em 
should be selected for 6 MV and a value in the range of 2.0" I" 2.5 em for 10 MV. 
5.3.4 Comparison of dose distributions in the lung geometry for 
standard fields and intensity modulated fields 
In the lung geometry, 20 dose distributions for standard fields and for 1.4 cm shorter 
fields with BIM were compared for a number of PTV s at different depths in the 
phantom. Figure 5.4a shows an isodose distribution measured for 10 MV at a depth of 
12.5 cm. The superior-inferior length of the PTV is 10.5 cm, so, conform to the rules 
mentioned in the previous subsection, boost fields with a length of 2.3 cm were used in 
the ElM technique: For the standard field, the minimum dose in the superior and 
inferior parts of the PTV is less than 90%, while this value increases to 95% when 
applying BIM, in spite of a reduction in field length of 1.4 cm. Due to BIM, the 50-
95% penumbra is reduced by 1.2 cm around the inferior part of the PTV and by 2.0 cm 
in superior direction (see figure 5.4b). Moreover, BIM allows an effective 
compensation for the reduced dose delivery in the field corners: the 50-95% penumbra 
is reduced from 3.7 to 2.0 cm (see figure 5.4a). In lateral direction the isodose 
distributions are similar for the standard field and the intensity modulated field (except 
around the superior and inferior field corners), since in ollr present study no attempts 
were made to improve the penumbra in that direction. 
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Figure 5.4 a lUeasured isodose distributions ill lung equivalent material at a depth of 
12.5 cmfor Irealmem of a PTI' (shaded area) with the 10 Ml' phOloll beam 
lIsillg Ihe slalldard field (dashed lilies) alld a 1.4 cm shorlerfield combilled 
with HIM (solid lilies). Depicled are the 20, 50, 90 alld 95% isodose levels. 
b Corresponding dose profiles in superior-illferior direction along the central 
axis. 
Figure 5.5 shows similar results for another PTV treated with the 10 MV photon beam. 
For the standard field and the intensity modulated field measured isodose distributions 
are compared in figure 5.5a. Predicted and measured dose profiles in superior-inferior 
direction along the central axis are depicted in figure 5.5c for both fields. For the 
standard field Cadplan predicts a minimum dose in the entire PTV of 95%, but in 
reality this value was less than 90% in the most superior end of the tumor volume 
(dashed lines in figures 5.5a, c). By selecting the length and the weight of the boost 
fields according to the rules mentioned in the previous section, underdosages in the 
most inferior and most superior parts of the PTV could be avoided with BlM, in spite 
of the reduced field length (solid lines in figures 5.5a, c). For BlM, measured and 
predicted isodose distributions are compared in figure 5.5b. Due to the inaccurate 
model in Cadplan for the increased lateral secondary electron transport in lung, the 
difference between predicted and measured doses equals 10% at the ends of the PTV. 
The higher dose differences compared with the standard field, which were about 5%, 
are due to the shorter field length used for BlM, resulting in a shorter distance between 
the PTV ends and the field edge. Application of BIM may result in a maximulll dose of 
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Figure 5.5 a lHeaSllred isodose distrUmtiolls ill hmg equivalent material at a depth 
of 12.5 ellifor treatlllellf of a PTV (shaded area) with the 10 MI' photon 
bealliusing the standardfield (dashed lines) and a 1.4 CIII slwrterfleld 
cOllibined with BIM (solid lines). Depicted are the 20, 50, 90 and 95% 
isodose levels. 
b Comparison between the measured isodose distribution jor the BIA1 
treatment (solid lines) {lnt! the distribution predicted by Ollr Cadplall 
treatment planning ~ystem (dashed lines), Depicted are the 20, 50, 90, 
95, 100 alld 105% isodose levels. 
c Measured dose profiles ill sliperiVl'~hiferior direction along the central 
axis for the stalldard field (dashed lille) alld BIM (solid lille) alld 
corresponding dose profiles predicted by our treatme1ll planning 
system (dots (lnd squares respect;\'ely). 
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Measured isodose distributions ill lung equivalent material at a depth of 
12.5 cm for treatment of a PTV (shaded area) with the 6 MV photoll 
beam ((sing the standard field (dashed lines) alld with a 1.4 cm shorter 
field combilled with BIM (solid lilies). Depicted are the 20, 50, 90 (/Ild 
95% isodose levels. 
b Comparison between the measured isodose distribution for the BI1\1 
treatment (solid lines) alld the distribution predicted by Ollr Cadplan 
treatment plallllillg system (dashed lilies). Depicted are the 20, 50, 90, 
95 alld 100% isodose levels. 
c l\1easllred dose profiles ill superior-illferior directioll along the central 
axis for the stalldard field (dashed lille) alld B1M (solid iiI/e) alld 
corresponding dose profiles predicted by aliI' treatment planning system 
(dots alld squares respectively). 
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110% near the ends of the PTV according to the treatment plan (see figure 5.5c), but in 
reality this value never exceeded 107% in any of our measurements. 
In figure 5.6 dose distributions for treatment of an identical PTV as in figure 5.5, using 
the 6 MV photon beam, are depicted. Again Cadplan predicts a minimum dose in the 
entire PTV of 95% for the standard field, but in reality tltis value was only 91 % 
(dashed lines in figures 5.6a, c). Due to the sharper 95-50% dose fall-off for 6 MV, a 
shorter length for the boost fields (1.6 instead of 2.3 cm) could be used compared with 
the previous example when applying BlM. Moreover, in accordance to the rules 
mentioned in the previous subsection, a lower weight for the boost fields was adequate 
to get a ntinimum dose of 95% in the PTV (solid lines in figures 5.6a, c). BIM reduced 
the 50-95% penumbra by 0.9 cm along the central axis in both the superior-inferior 
direction and in the corners of the treatment field. Measured and predicted isodose 
distributions for BlM are depicted in figure 5.6b. Due to the smaller effect of increased 
lateral secondary electron transport in lung for 6 MV, the differences between 
predicted and measured doses did generally not exceed 6%, yielding a maximum dose 
in the PTV of less than 105% according to the treatment plan. 
5.3.5 Comparison of dose distributions in the tumor geometry for 
standard fields and intensity modulated fields 
Compared with the lung geometry, the 95-50% dose fall-off is sharper in the tumor 
geometry (1.6 instead of 1.9 cm for 10 MV), due to the penetration of secondary 
electrons generated in the edges of the high density GTV into the low density lung 
tissue of the PTV (see figure 5.7). As a result, the 95% isodose does encompass the 
PTV for the standard field (field margin 1.5 cm), both for the 6 and the 10 MV photon 
beams. However, by applying BIM, a sintilar dose distribution in the PTV can be 
obtained with a reduction in field length of 1.4 cm. Due to the lateral secondary 
electron transport from the GTV into the penumbra regions, the dose calculations of 
the treatment planning system are more accurate in the tumor geometry than in the lung 
geometry; the difference between calculated and measured doses is reduced to a 
maximum of 5% for 10 MV. Therefore, the weight of the boost fields for 10 MV may 
be reduced so that the planned minimum dose on the superior and inferior ends of the 
PTV just exceeds 100% of the isocenter dose, like for the 6 MV photon beam. 
Figure 5.7 a 
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lWeasured isodose distributions/or treatment of the PIV (shaded area) 
ill the 'tlllllOr geomefl), ' (depicted ill figure 5.2) at a depth of8 cm with 
the 10 MI' photoll beam usillg the stalldard field (dashed lilies) alld a 
1.4 cm sllOrter field combilled with BIM (solid lilies). Depicted are the 
20, 50, 90 alld 95% isodose levels. 
b Corresponding dose profiles along the cellfral axis in sllperior-it{ferior 
dh'ection. 
58 Chapter 5 
5.4 Conclusions 
The results of this dosimetric study show that, in spite of the increased lateral 
secondary electron transport in lung tissue, BIM can effectively be used for penumbra 
enhancement and superior-inferior field length reduction in lung cancer treatments, 
whilst achieving adequate tumor coverage. Due to a field length reduction of 1.4 cm, 
BIM yields reduced dose delivery to the healthy lung tissue, as was demonstrated by 
the results of our treatment planning study described in the previous chapter. In 
contrast to the use of this technique for treatment of prostate cancer patients, the boost 
fields which are superimposed on the superior and inferior ends of the treatment fields 
have to be longer and of a higher weight in order to compensate for the effects of 
increased lateral secondary electron transport in lung tissue. The Cadplall treatment 
planning system does not correctly account for this increased lateral electron transport, 
but practical rules for selecting the length and the weight of the applied boost fields 
could be derived to circumvent this problem. Using these mles, underdosages in the 
superior and inferior parts of the PTV could be avoided in spite of the reduction in 
field lengths with respect to the fields used in our present treatment technique. In 
contrast, with the present standard technique for lung cancer treatments, underdosages 
in the superior and inferior ends of the PTV do usually occur, despite the use of 
superior-inferior field margins of 1.5 cm or larger and a minimum PTV dose of 95% of 
the isocenter dose as predicted by the treatment planning system. Clearly, there is a 
pressing need for more accurate dose calculation algorithms which correctly model the 
effect of electron density on lateral secondary electron transport, in order to enable 
quantification of the actual dose delivery in clinical lung cancer treatments, e.g. by 
using dose volume histograms and (normal) tissue complication probabilities. The 
availability of correct dose volume histograms may also facilitate the design of dose 
escalation studies for lung cancer treatments. Due to the sharper beam penumbrae 
around the superior and inferior field edges, clinical application of the proposcd BIM 
technique puts higher demands on the accuracy of the definition of the GTV in 
superior and inferior direction and the inclusions of adequate margins between the 
GTV and the PTV to account for patient set -up inaccuracies and internal organ motion 
due to breathing. 
In this dosimetric study the advantages of BIM for penumbra enhancement and field 
length reduction in superior-inferior direction were demonstrated for single fields. By 
realizing these effects for every single beam, this technique can effectively be used in 
coplanar lung treatments. 
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Leaf trajectory calculation for dynamic multileaf collimation 
to realize optimized fluence profiles 
Adopted from the original article by MLP DirlO(, BJM Heijmen and JPC van 
Santvoort, published in Phys. Med. Bioi. 43: 1171-1184, 1998. 
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6.1 Introduction 
Dose distributions can often be significantly improved by applying intensity modulated 
X -ray beams, calculated by means of inverse treatment planning techniques [12,17,56, 
68,91,104,114,134,137,164,166-168]. Using customized beam profiles, the high dose 
region can often be conformed more closely to the target volume, reducing the dose 
delivered to surrounding critical organs and normal structures. Moreover, for some 
tumor sites, e.g. in the head and neck region, a more homogeneous dose distribution in 
the target volume can be obtained. 
One way of realizing intensity modulated beam profiles is the use of compensators. 
However, compensators have several drawbacks. First of al1, their production is labor-
intensive and time consuming. Since they have to be changed manually for each 
treatment field, their use is time consliming during treatment delivery as well. For this 
reason, only a limited number of compensators can generally be used in clinical 
practice. Another drawback is the need for models to accurately include scattered 
photons and beam hardening, as produced by the compensators, in the dose 
calculations. 
A second way to produce intensity modulated beams is the superpositioning of a 
number of partially overlapping, static, irregularly shaped fields produced with a 
mu1tileaf collimator (MLC). Examples of this method have been described in chapters 
3 and 4 and by Bortfeld et a/ [13] and Galvin et a/ [51], Ft'aass et a/ [50] and de Neve 
et a/ [35,36]. Probably the most flexible way is the use of dynamic multileaf 
collimation, scanning beams or a combination of both techniques [28,57,135,136,138, 
147,158,165,169]. 
For dynamic multileaf collimation, several analytical algorithms have been described in 
recent years for the calculation of the required leaf trajectories to realize an optimized 
f1uence profile employing the sliding window technique [29,135,138,147]. This 
technique is based on moving each leaf pair of the MLC independently but 
unidirectionally across the treatment field while the beam is on, effectively sweeping 
apertures of variable widths across the field. 
To reduce leakage radiation between adjacent leaves of a multi leaf collimator, all 
commercially available MLCs have a so-called tongue-and-groove arrangement (see 
figure 6.1). A disadvantage of such an arrangement is that it can yield serious 
underdosages both in the case of superpositioning of multiple static fields and for 
dynamic multileaf collimation [112,158]. Recently, van Santvoort and Heijmen [158] 
have presented a method for leaf trajectory calculation for dynamic multi leaf 
collimation, which fully avoids tongue-and-groove underdosage effects by 
synchronization of the trajectories of adjacent leaves. Webb et a/ [169] refined this 
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Figure 6.1 Tongue-and-groove arfangemellf o/the MM50 lllulti/eaJ collimator. 
method by allowing also partial synchronization, accounting for the effect of increased 
leaf transmission in the tongue-and-groove area. 
In the article of van Santvoort and Heijmen [158] leaf transmission and collimator 
scatter were not accounted for. In this chapter an iterative algorithm for leaf trajectory 
calculation is presented that docs take into account transmission and collimator scatter, 
while still avoiding tongue-and-groove underdosage effects. To assess the accuracy of 
this algorithm in combination with the Cadplan 3D treatment planning system (Varian-
Dosetek), predicted absolute dose distributions for optimized fluence profiles were 
compared with dose distributions measured for the 25 MV photon beam of the MM50 
Racetrack Microtron using dynamic multileaf collimation. The required leaf 
trajectories resulted from calculations with the presented algorithm. Prediction of dose 
distributions was performed using the pencil beam algorithm as implemented in the 
Cadplan system [140,142]. 
6.2 Iterative algorithm for leaf trajectory calculation 
Starting point for the calculations are optimized fluence profiles Fop,(k,x) for all leaf 
pairs k, expressed in monitor units and calculated by inverse treatment planning 
techniques. taking into account off-axis variations in the primary beam fluence profile 
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of the accelerator. A t1uence of I MU corresponds to the t1uence that resuits in a dose 
delivery of I cOy at the depth of dose maximum in water for a static IOxlO cm' field 
using a source to surface distance of 100 cm. The optimized t1uence profiles are 
realized with the sliding window technique with the leaves moving across the field 
from left to right. 
The iterative calculation of the leaf trajectories is started by assuming that for each leaf 
pair k the required monitor unit profile MUo(k,x), defining for each position x the 
number of monitor units that one of the two leaves of a leaf pair should not block x in 
order to realize Fopt(k,x), is equal to the optimized t1uence profile, i.e.: 
MUo(k,x) = F'"p,(k,x) (6.1) 
In iteration step i, the leaf trajectories for all leaves are determined from the profiles 
MU i . j using the method described by Van Santvoort and Heijmen [158]. Next, forward 
calculations of the resulting t1uence profiles F; are performed, taking into account both 
collimator scatter and leaf transmission (see also figure 6.2): 
MUL/x) 
F, (k,x) = J S,/k,MU)dMU +T[MUtot ., -~ULJ(k,x)-MUR/k,x)ll (6.2) 
For each leaf pair k, the fll'St term of equation 6.2 describes the t1uence delivered to 
position x while it is unblocked by the opposing leaves, i.e. during the period that the 
right leaf has passed position x (i.e. MUR.i(k,x) monitor units after the iITadiation 
started) and the left leaf has not yet reached this position (i.e. MUL,i(k,x) monitor units 
after the iImdiation started). The collimator scatter factors S,(k,MU) for the in'egularly 
shaped fields at times MU are derived frOlllll1eaSured values for rectangular fields. For 
each leaf pair k, the leaf opening at time MU is determined. Together with the field 
length, defined by the collimator blocks, the leaf opening of pair k defines a 
rectangular field. The collimator scatter factor of this rectangular field, obtained by 
interpolation of measured values, is taken as the collimator scatter factor S,(k,MU). 
The second term in equation 6.2 describes the t1uence contributions due to the effective 
transmission under the moving leaves during the periods that x is blocked by one of the 
two leaves of a leaf pair. This effective transmission includes both transmission 
through the leaves and the effect of extra-focal radiation, originating from the 
periphery of the focus at the target and from the collimator blocks [63,142). MUtot.i is 
the total number of monitor units needed to realize the t1uence profile. 
The calculated t1uence profiles in iteration i, FiCk,x), are compared with the optimized 
profiles FoPt(k,x), and the MU-proftles are adjusted for the next iteration: 
Figure 6.2 
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MUj (k,x) = MUI-I(k,x)-(F, (k,x)-Fop,(k,x) (6.3) 
The iteration continues until for each position and leaf pair the difference between the 
realized and the optimized fiuence profile is less than a predetermined tolerance level 
or until the overall difference, indicatcd by the nus deviation, is not decreasing 
significantly between successive iterations. 
6.3 Materials and methods 
6.3.1 Measurement of collimator scatter factors 
Collimator scatter factors needed for leaf trajectory calculations have been measured 
for rectangular fields using an RK chamber (volume 0.13 cc), vertically positioned in a 
brass build-up cap with a cylindrical side wall of 2 gcm" and a front wall of 10 gcnf' 
[89]. In order to have the radiation field fully encompassing the used build-up cap, the 
source-to-surface distance was extended from 100 to 250 cm for the smallest fields. For 
fields with leaf openings of less than I cm, measurements were also performed with 
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TLD, positioned in a build-up cap with side and front walls of the same thicknesses as 
mentioned before, but with a smaller outer diameter. Measurements were performed on 
the beam axis for leaf openings ranging from 0.4 to 10 cm and field lengths of 5, 10 
and 15 cm. 
To verify the method, explained in section 6.2, for calculation of collimator scatter 
factors for the long, nmTOW and irregularly shaped fields observed in dynamic multileaf 
collimation, collimator scatter factors have also been measured for many of those 
fields. Leaf settings for the irregularly shaped fields were derived from optimized 
f1uence profiles using the algorithm described in the previous section. For the 
measurements the leaf positions were shifted so that the two middle leaf pairs were 
centered around the beam axis. The measurements were performed with an RK-
chamber on the beam axis using the same experimental set-up as for the rectangular 
fields. 
In the method presented in section 6.2 the collimator scatter factor is assumed to be 
independent of position within the field. To verify this assumption, doses were 
measured in the center of fields of 1.6x 10 cm', centered around off-axis positions of 
2.5, 5, 7.5, 10 and 12.5 cm. Each dose, normalized to the dose for the on-axis 1.6xlO 
cnl field, was compared with the corresponding normalized primary fluence profile as 
measured with the leaves and collimator blocks completely opened. All measurements 
were performed with the RK-chamber vertically positioned in the build-up cap 
mentioned above. 
6.3.2 Measurement of transmission through the leaves 
The transmission through the leaves has been measured in a water phantom (RFA-300, 
manufactured by Scanditronix Medical AB) using a linear diode array consisting of II 
p-typc diodes, and with film, irradiated perpendicularly to the beam axis in a 
polystyrene phantom [153]. In the latter case, measured optical densities were 
converted into doses by applying a sensitometric curve determined for the beam axis of 
a 10xiO cm2 field using the same set-up. Measurements were made for a OxlO cm2 
lleld, i.e. with the leaves fully closed and the collimator blocks set to an opening of 10 
cm. The transmission was determined by normalizing the results to the dose measured 
at the same position for a 10xi0 cm2 field, using the same number of monitor units. 
For all measurements the source to surface distance was 100 cm. 
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6.3.3 Realization of f1uence profiles at the MM50 Racetrack Microtron 
The dual gantry MM50 Racetrack Microtron is equipped with a double focused 
multi leaf collimator suited for shaping both photon and electron beams [46,71]. 
Projected at isocenter, the lcaves have a width of 1.25 cm and a range of travel of 16 
em from the beam axis to 14 cm across it. The maximum leaf speed is 1 cm S~I and the 
maximum doserate is 5 MU S-I. Arbitrary fiuence protlles can be generated clinically 
using dynamic multileaf collimation, which is fully integrated in the clinical treatment 
mode. For DMLC, a treatment field is divided into a number of so-called subsegments. 
The first subsegment (start segment) defines the positions of the leaves when the 
irradiation is started, the last one (stop segment) defines their positions when the beam 
is turned off. Additional, intermediate subsegments are used to change the speed of the 
leaves during the irradiation. While the number of monitor units associated with a 
subsegment is delivered, each leaf moves with an appropriate constant velocity 
(cm/MU), calculated by the control system of the accelerator, to the position defined 
for the next subsegmenL By definition, the number of monitor units for the stop 
segment is zero. The maximum number of allowed subsegments equals 48. 
For realization at the accelerator, the continuous leaf trajectories, as calculated with the 
method described in section 6.2, are subdivided into 48 subsegments. A simple method 
for this segmentation would be based on an identical number of monitor units for each 
subsegment. However, using this method, unnecessary subsegments may then be 
defined in periods that the velocities of the leaves do not change significantly, leaving 
too few segments to accurately account for large velocity changes in other periods, 
resulting in substantial deviations between calculated continuous leaf trajectories and 
segmented leaf trajectories. To minimize these deviations another method for 
segmcntation is used. In this method, the calculated velocity changcs of the leaves are 
ranked from high to low. To define the intermediate subsegments additional to the start 
and stop segment, the times at which the 46 highest velocity changes occur are then 
used. However, defining two separate subsegments at nearly the same time of the 
irradiation does not substantially improve the accuracy of segmented leaf trajectories. 
Therefore, one refinement was made to the described method. The number of monitor 
units associated with a subsegment should be at least MUlOt! 2(N-l). (MUlot indicates 
the number of monitor units needed to realize the fiuence profile and N is the number 
of subsegments.) Definition of the 46 intermediate subsegments is then based on the 
previous mentioned ranking of velocity changes, while skipping segmentations that 
would be too close to previous segmentations, as defined above. 
The leaf positions and monitor units for each subsegment are transferred to the MM50 
by network and are stored in the paticnt database. 
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During a DMLC treatment the leaf positions are verified every 0.08 seconds by 
comparing the actual values, measured with potentiometers, with the prescribed 
positions. In case for one of the leaves the deviation exceeds the preset tolerance level 
for more than a preselected number of subsequent measurements, the treatment is 
terminated. Presently, these tolerance levels have been set to 0.2 cm and to 3 times, in 
order to avoid that a treatment is unnecessarily terminated in case a leaf position 
appears to deviate strongly from its prescribed position due to electronic spikes on the 
readout signal. For reasons of treatment time efficiency and potential hardware 
problems with the leaves during DMLC operation, 0.2 cm was also chosen as the leaf 
position tolerance for the Varian MLC at the Memorial Sloan-Kettering Cancer Center 
[92). 
6.3.4 Dosimetric verification of leaf trajectory calculations 
The method for leaf trajectory calculation was tested for the 25 MV photon beam of the 
MM50 Racetrack Microtron for a wide range of fluence profiles. Both model cases and 
real clinical cases were studied. To verify the method for leaf trajectory calculation, 
absolute dose distributions were measured for fields realized with the calculated leaf 
trajectories. These measured dose distributions were compared with calculated dose 
distributions derived from corresponding optimized fluence profiles by convolution 
with a pencil beam [140,142], as implemented in the Cadplan treatment planning 
system. Relative dose profiles were measured in a water phantom at different depths, 
using a linear diode array consisting of II p-type diodes, and with film, irradiated 
petpendicularly to the beam axis in a polystyrene phantom. In the latter case, measured 
optical densities were converted into doses by applying a sensitometric curve as 
described before. For all measurements the source to surface distance was 100 cm. 
Absolute dose measurements, needed for normalization of the relative dose profiles, 
were performed with an ionization chamber in a relatively flat part of the beam profile. 
6.4 Results and discussion 
6.4.1 Collimator scatter factors needed for leaf trajectory calculation 
In figure 6.3, measured collimator scatter factors, determined relative to a IOxlO cm2 
field, are depicted for the 25 MV photon beam of the MM50. It was verified that within 
the accuracy of the measurements the collimator scatter factor did not depend on the 
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Figure 6.3 Measured colli/llator scatterjactorsjor rectal/gularfieids lI'ithfield lel/gths oj 
5, 10 and 15 cm respectively /Ising {/II RK chamber (lines) or TLD (points). 
detector type (RK chamber or TLD) and the source-to-surface distance (100 or 2S0 
cm). It is clear that for a fixed field length the variation of the collimator scatter factor 
is rather small (less than 4%) for leaf openings larger than 0.8 cm. This variation is in 
agreement with previously described results [180] when no flattening filter is present, 
like on the MMSO. For smaller leaf openings the collimator scatter factor decreases 
dramatically. Using a similar measurement technique as suggested by Huang et al [60], 
it was concluded that backscatter of radiation into the monitor chamber is absent for 
the MMSO. Therefore, the large decrease in collimator scatter factors for small field 
openings should be explained by blocking of photons originating from the periphery of 
the focus at the target as described by Zhu and Bjarngard [180]. 
6.4,2 Verification of predicted collimator scatter factors for irregularly 
shaped fields and off-axis positions 
Measured and predicted collimator scatter factors have been compared for 116 
different irregularly shaped fields. Since the measurements were made on the beam 
axis, the average predicted collimator scatter factor for the two leaf pairs adjacent to 
the beam axis was used in this comparison. As an example the shapes of six irregularly 
shaped l1elds and the corresponding measured and predicted collimator scatter factors 
are depicted in I1gure 6.4. 
Figure 6.S shows a histogram of the observed ratios between the measured and 
predicted values for leaf openings of 0.7 cm and larger (N= 112). On average, this ratio 
68 
Figllre 6.4 
Se,rn 0.963 
S.,.p 0.969 
Chapter 6 
• • • • • 
0.973 0.978 0.968 0.971 0.971 
0.975 0.978 0.967 0.974 0.972 
2,m 
+-----+ 
Examples of irreglliarly shaped fields IIsed to verify aliI' method to 
predict the col/imator scatter Jactor. SC,/II alld Sc,p are measured alld 
predicted collimator scaller/ac/ors in tile indicated points respectively. 
equals 0.996±0.003 (I SO), which means that our model makes a small overestimation 
of the S, factors. One reason for this rather good agreement is the fact that very 
hTcgularly shaped apertures are avoided as a result of the synchronization of the leaf 
trajectories (see section 6.2). 
For leaf openings smaller than 0.7 cm differences between predicted and measured 
collimator scatter factors up to 5% have been observed. However, from figure 6.3 it is 
clear that these deviations can already be explained by an enol' of 0.05 em in the actual 
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leaf openings. A small deviation of the detector from the center of the fields can 
explain these deviations as well. Generally, when using dynamic multileaf collimation, 
the leaf openings are larger than 0.7 cm during most of the treatment. Only for the first 
and last few monitor units the leaf openings are smaller, resulting in a less accurate 
prediction of the collimator scatter factor. This inaccuracy does only affect the 
accuracy of the calculated fluences in the penumbra regions of the fields. 
The normalized doses for the off-axis positioned 1.6xlO cm' fields (see section 6.3.1) 
agreed within 0.6% with the normalized primary fluence profile. Therefore, in equation 
6.2 on-axis collimator scatter factors can indeed be used for off-axis positions. More in 
general, the validity of using on-axis measured Sc factors in off-axis positions is 
confirmed by the close on- and off-axis agreement between calculated and predicted 
dose profiles (see section 6.4.5). 
6.4.3 Effective transmission through the leaves 
For the 25 MV photon beam of the MM50, both film and diode measurements yielded 
an (average) transmission through the leaves of 0.8% at a depth of 3.5 cm. The 
interleaf leakage was less than 2%. 
Assuming a negligible extra-focal radiation, the first comparisons of measured and 
predicted dose distributions for intensity modulated beams were made using a value for 
the effective transmission T in equation 6.2 of I %. A systematic underestimation of the 
predicted dose distributions was then found. In later runs, the effective transmission 
was used as a tuning parameter. It was concluded that the best overall agreement could 
be achieved assuming an effective transmission of 2%, which by coincidence equals 
the interleaf leakage (see above). This value is only slightly higher than the 1.5% that 
was used by Storchi et al [142] in their calculation for dynamic wedges on Varian 
Clinacs. 
6.4.4 Iterative calculation of leaf trajectories 
In figure 6.6, a typical example is presented of the results of our iterative method for 
leaf trajectory calculation. As indicated in the previous subsection, a value for the 
effective transmission T of 2% was applied in equation 6.2. For cach monitor unit, the 
collimator scatter factors S,(k,MU) as used in equation 6.2 were determined by 
interpolation from the data in figure 6.3 using the field length and the leaf opening (see 
section 6.2). After one iteration, large differences (up to 10%) are observed between 
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the realized fIuence profile FJ and the optimized fIuence profile Fopt ' Generally, after a 
second iteration these differences are already reduced to less than 0.2 MU, except at the 
edges of the field. This is related to the very small leaf openings at the beginning and at 
the end of the irradiation, resulting in S, factors that strongly deviate from 1. Generally 
after 3 to 10 iterations, the differences between the realized and optimized fIuence 
profiles are less than 0.1 MU for all points within the treatment field, except for those 
with an optimized fIuence less than 2% of the total number of monitor units needed to 
realize the profile. Such a low fIuence can never be realized due to the unavoidable 
transmission through the leaves. 
After segmentation in 48 subsegments, the agreement between the realized and 
optimized fIuence profiles generally remains within 0.5 MU for most points within the 
field. An increase in the maximum number of subsegments, requiring a modification of 
the control software of the accelerator, will improve the accuracy after segmentation. In 
the meantime, dose distributions can be derived from the segmented fIuence profiles, to 
make sure that the remaining differences between the segmented and the optimized 
fIuence profiles do not yield clinically unacceptable results. 
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6.4.5 Dosimetric verification of leaf trajectory calculation 
In figure 6.7, a comparison is made between measured and predicted absolute dose 
profiles at depths of 3.5, to and 20 cm for three ID model cases, i.e. with identical 
modulated flllence profiles for all leaf pairs. The field length was to cm for the first 
two flllence profiles and 12.5 cm for the third one. 
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Figures 6.8 and 6.9 show the results for two clinical cases: an optimized fluence profile 
used for treatment of a prostate cancer patient (figure 6.8a) and one used for the 
elective treatment of a patient with a head and neck cancer (figure 6.9a). Figures 6.8b 
and 6.9b show the isodose distributions for a depth of 3.5 cm. In figures 6.8c and 6.9c 
dose profiles at an off-axis distance of 0.7 cm (through the middle of a leaf pair) and at 
depths of 3.5, 10 and 20 cm are compared. For all cases, measured and predicted dose 
distributions agreed within 2%, or within 0.2 cm in regions with a high dose gradient. 
6.5 Conclusions 
An iterative method for leaf tntiectory calculation is described which takes into account 
transmission and collimator scatter, while avoiding tongue-and-groove underdosagc 
effects. To achieve a maximum difference between optimized and realized fluence 
protlles of 0.1 MU for each point within the treatment field, generally less than 10 
iterations are necessary, taking only a few seconds on a HP9000/C 110 workstation. 
Absolute dose measurements show that the accuracy of our method for leaf trajectory 
calculation in combination with the dose calculation algorithm of the Cadplan 3D 
planning system is adequate for clinical application. 
Chapter 7 
Testing of the stability of intensity modulated beams 
generated with dynamic multileaf collimation, 
applied to the MM50 Racetrack Microtron 
Adopted for the origillalmanuscript by MLP Dirkx and BJM Heijmen, to be published 
in Met!. Ph),s. 27 (12), 2000. 
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7.1 Introduction 
Treatment plans can often be significantly improved by applying intensity modulated 
X-ray fields, calculated by means of inverse treatment planning techniques [12,16,17, 
56,68,91,104,114,134,137,164,166-168]. Especially for concave shaped targets, the 
use of optimized beam profiles generally allows a closer conformation of the high dose 
region to the target volume, while reducing the dose in surrounding critical organs and 
normal stmctures. A flexible way of delivering intensity modulated beam profiles is 
dynamic multileaf collimation (DMLC) with the sliding window technique [29,40,135, 
138,147,158]. This technique is based on a continuous, independent and unidirectional 
movement of each leaf pair of a multileaf collimator (MLC) across the treatment field, 
while the beam is on. In thevrevious chapter a method for calculation of the required 
leaf trf\jectories to realize optimized intensity modulated beam profiles was presented. 
Using an iterative method, leaf transmission and collimator scatter were accounted for 
and tongue-and-groove underdosage effects could be fully avoided. For the MM50 
Racetrack Microtron (Scanditronix Medical AB) it was demonstrated that measured 
absolute dose distributions resulting from the calculated leaf trf\jeetories and dose 
distributions predicted with the dose calculation algorithm of the Cadplan 3D planning 
system (Varian) generally agreed within 2%, or 0.2 cm in regions with high dose 
gradients. 
Before implementing DMLC in their clinical practice, Chui et al [28] and LoSasso et al 
[92] designed and conducted tests to examine the mechanical accuracy of a Varian 
tllultileaf collimator in DMLC mode and its impact on the dose delivery of intensity 
modulated beams realized with DMLC. As a final test before starting patient treatment 
with DMLC on our MM50 Racetrack Microton, some of these tests were also 
performed. Complementary dosimetrical tests were performed to verify, (i) the long 
term stability of intensity modulated beam profiles, (ii) the stability of these profiles 
subject to gantry rotation, and (iii) the sensitivity of DMLC treatments to treatment 
interrupts, c.g. caused by an error detected by the treatment machine. 
7.2 Methods and materials 
7.2.1 Dynamic multi/eat collimation at the MM50 Racetrack Mlcrotron 
The dual gantry MM50 Racetrack Microtron is equipped with a double focused 
multileaf collimator. Due to the scanning beam principle and the helium in the 
treatment head, the MLC can be used for shaping of both photon and electron beams 
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[46,71]. Projected at isocenter, the leaves have a width of 1.25 cm and a range of travel 
of 15.5 cm from the beam axis to 14 cm across it, yielding a maximum field size of 
31x40 cm'. Servomotors control the leaf movement. For each leaf the actual leaf 
position is derived from a potentiometer reading. Redundant readout is not available. 
The maximum leaf speed is I cm s·'. 
The MLC of the MM50 is calibrated by successively positioning the leaves at five 
positions (-14, -7, 0, 7 and 15 cm) using the light field, and storing the corresponding 
readouts of the potentiometers in a file. To position a leaf at an intennediate position, a 
lineal' interpolation between the stored calibration values is used. When setting up an 
MLC field, a driving conunand is sent by the MLC control system to the servomotor of 
each leaf. The actual readout of the cOlTesponding potentiometers is used as a feedback 
for leaf positioning. Based on the setup of 1237 static fields, it has been demonstrated 
that the precision of the MLC control system in terms of static field definition is within 
0.05 cm at 97% confidence level [108]. 
Arbitrary fluence profiles can be generated using dynamic multileaf collimation, which 
is fully integrated in the clinical treatment mode of the MM50. The profiles are 
generated with fixed doserates, which are the same as those used for static fields. The 
applied doserate is 3.3 MU s·, for the 10 MV photon beam and 5 MU s·, for the 25 MV 
beam. For DMLC, a treatment field is divided into a number of so· called subsegments. 
The first subsegment (start segment) defines the positions of the leaves when the 
llmdiation is started, the last one (stop segment) defines their positions when the beam 
is turned off. Additional, intermediate subsegments are used to change the speed of the 
leaves during the irradiation. While the number of monitor units associated with a 
sllbsegmcnt is delivered, each leaf moves with an appropriate constant velocity 
(cm/MU), calculated by the control system of the accelerator, to the position deflned 
for the next subsegment. By definition, the number of monitor units for the stop 
segment is zero. During a DMLC treatment the leaf positions are verifled every 0.08 
seconds by comparing the actual values, measured with potentiometers, with the 
prescribed positions. In case for one of the leaves the deviation exceeds the preset 
tolerance level for more than a preselected number of subsequent measurements, the 
irradiation is stopped. These tolerance levels, which do not effect the leaf position 
accuracy, have been set to 0.2 em and to 3 times, in order to avoid that a treatment is 
unnecessarily terminated in case a leaf position appears to deviate strongly from its 
prescribed position due to elcctronic spikes on the readout signal. For reasons of 
treatment time efficiency and potential hardware problems with the leaves during 
DMLC operation, 0.2 em was also chosen as the leaf position tolerance for the Varian 
MLC at the Memorial Sloan-Kettering Cancer Center [92]. 
In addition to the leaf position verification every 0.08 seconds during a DMLC 
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delivery, the actual leaf positions and the number of monitor units delivered by the 
treatment unit are logged in a file every two seconds. By comparing these data with the 
prescribed leaf trajectories, the accuracy of the realized leaf positions at fixed times 
during the treatment can be assessed retrospectively. 
The required leaf trajectories to realize an optimized intensity modulated beam profile 
by dynmnic multileaf collimation are calculated using the algorithm that was described 
in the previous chapter, including leaf transmission and collimator scalier. A sliding 
window technique is applied in which the leaves are moving across the field from left 
to right. The leaf motions of adjacent leaf pairs are synchronized to avoid underdosage 
effects in the tongue-and-groove overlap [158]. The calculated leaf trajectories and 
conesponding monitor units are transferred to the MM50 by network and are stored in 
the patient database. 
7.2.2 Stability of leaf positioning in DMLC mode 
In DMLC mode the dose delivered in the treatment field is directly affected by the 
width of the sliding gap sweeping across the field. Recently, Budgell et al 
demonstrated that realization of intensity modulated beam profiles, calculated by 
inverse planning, lIsing dynamic lllultileaf collimation, definitely requires a leaf 
position accuracy better than I mm, to avoid large dose errors, both in regions with 
relatively flat beam profiles and in regions with high dose gradients [20]. To verify the 
accuracy and stability of leaf positioning in the DMLC mode of the MM50 Racetrack 
Microtron, we implemented a quality assurance test as proposed by Chui et a/ [28). In 
our version, a O.lx40 cnl slit beam was swept across the field. At 7 em intervals, each 
leaf pair was forced to stop during 100 MU, yielding narrow hot spots. Film 
measurements were performed in a polystyrene phantom using the 25 MV photon 
beam. The films were positioned pelpendicularly to the beam axis at the depth of dose 
maximum, at 100 cm from the focus. If the leaves were positioned correctly, film 
measurements would show straight dark lines at equal distances, on top of a light 
background. The accuracy of leaf positioning could be assessed within 0.05 cm by 
viewing the films on a light box. Smaller leaf positioning errors could be detected after 
scanning the films on a Lumiscan 75 laserdensitometer (Lumisys), using a spot size of 
0.014 cm. A sensitometric curve, derived from fihns irradiated in a static lOxlO cnl 
field with various numbers of monitor units, using the same experimental setup as 
described above, was applied to convert measured optical densities into doses. 
The stability of gap widths was investigated by dose measurements in the center of a 
uniform lOx 10 em' field that was delivered dynamically by sweeping a O.4xlO cm' slit 
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beam as proposed by LoSasso et al [92]. A NE 2571 ionization chamber was used, 
which was positioned at a depth of 5 cm in a polystyrene phantom. The source to 
smface distance was 100 cm. To conect for output variations (Le. cGy/MU-ratio) of 
the accelerator in static fields, both in time and for different gantry angles, each 
measured dose value was divided by the dose measured in the center of the 
conesponding static lOx 10 cm2 field. Due to the narrow leaf gap used in this 
experiment, the measured dose was highly sensitive to the exact gap width; a deviation 
of only 0.01 cm would result in a dose difference of about 2.5% [92]. 
7.2.3 Long term dosimetric stability 
Day-to-day variations in dose distributions realized with DMLC were assessed by 
performing dose measurements with an ionization chamber and with a SRI-100 
electronic portal imaging device (EPID) for gantry angle 0°. The SRI-100 is a 
fluoroscopic system, basically consisting of a fluorescent screen, two mirrors and a 
CCD camera [1,163]. The CCD-chip consists of 512 x 256 pixels, with a pixel size 
projected at isocenter of about 0.05 x 0.08 cm2• The distance from the focus to the 
fluorescent screen is 160 cm. For the 10 MV photon beam, measurements were 
performed at an effective depth of 2 cm and for the 25 MV beam at a depth of 2.5 cm 
[121]. The EPID has favorable characteristics for dosimetric applications: on-axis pixel 
values reproduce within 0.5% and, after cOlTection for observed on-axis fluctuations, 
off-axis pixel values reproduce within 0.2% [38,59]. Except for verification and 
con'ection of the daily patient setup during a radiotherapy treatment, the EPID is used 
for dosimetric quality control measurements and in-vivo dosimetry in our institution 
[38,59,76,77,118,121-124]. 
In our present application, signals were integrated on the CCD chip during periods of 
240 ms. The final image was derived by averaging 120 successive camera frames 
which were only corrected for dark current, measured just before irradiation started. 
Acquisition of 120 frames allowed full coverage of the beam-on time for the DMLC 
fields that were tested. The portal images were analyzed by calculating average pixel 
values in areas of OAxO.8 cnl. Relative dose profiles were derived by normalizing 
these pixel values to the measured pixel value in a reference point in a relatively flat 
part of the beam profile. The dose in this reference point was measured with an 
ionization chamber positioned at the depth of maximum dose in a waterequivalent 
phantom. To enable a correction for day-to-day variations in the output (Le. cGy/MU-
ratio) of the accelerator, the dose in the center of a static IOxlO cm2 field for 200 MU 
was measured as well. 
80 Chapter 7 
7.2.4 Dosimetric stability under gantry rotation 
To investigate the influence of gravity on delivered dose profiles, intensity modulated 
beam profiles were realized under different gantry angles. Relative dose profiles, 
normalized to a reference point, were measured using the SRI-IOO (see previous 
subsection) and a linear diode array (Scanditronix Medical AB) attached to the 
collimator. The diode array consists of II p-type diodes with a spacing of 2.5 cm. For 
the measurements, a final resolution of 0.25 em was achieved by moving the array and 
repeating the DMLC delivery ten times. The dose in the reference point was measured 
in a polystyrene phantom at the depth of maximum dose, using a NE 2571 ionization 
chamber. 
7.2.5 Sensitivity to treatment interrupts 
Generally, effects of acceleration and deceleration of the leaves are neglected in 
calculation methods to derive leaf trajectories required to generate optimized intensity 
modulated beam profiles [40,135,138,147]. If these effects are significant, deviations in 
dose profiles may be observed when during a DMLC treatment the Icaf movement is 
forced to stop due to an interrupt by the treatment machine, and is restarted afterwards. 
To analyze these effects, films (Kodak XV), which were positioned perpendicularly to 
the beam axis in a polystyrene phantom at 5 cm depth, were irradiated. The source to 
surface distance was 100 cm. Measured optical densitics wcre converted into doses by 
applying a sensitometric curve (see subsection 7.2.2 for more details). For this test a 
2D intensity modulated beam profile was uscd with identical I D fluence profiles for 
groups of five adjacent leaf pairs, allowing the effect of treatment interrupts to be 
analyzed carefully for different ID beam profiles at the same time. In total 190 monitor 
units were delivered. To allow multiple fluctuations on each fluence profile, each 
treatment was intermptcd manually three times and restarted afterwards. The films 
were normalized to the dose in the center of a flat profile, being one of the ID fluence 
profiles. Measured dose profiles were compared with dose profiles for uninterrupted 
treatments. 
Testing of the stability of DMLC 81 
7.3 Results and discussion 
7.3.1 Stability of leaf positioning in DMLC mode 
Figure 7.1 shows part of a film irradiated with the sweeping 0.1 cm wide slit beam. By 
viewing these films on a light box it was concluded that in an 80 days period the 
stability of leaf positioning was within 0.05 cm. During this period no recalibration of 
the leaves was necessary. Variations in optical density, e.g. visible in figure 7.1 at the 
bottom left, point at small differences «0.05 cm) in gap widths related to the accuracy 
of leaf calibration. For these nalTQW slit beams, the measured optical density is highly 
dependent on the actual gap width, because the beam focus is partly blocked by the 
leaves, affecting the number of photons that can reach the film [40]. 
During a period of 80 days, dose measurements were performed in the center of a 
uniform lOx 10 cm' field, as realized by swccping a 0.4 cm wide slit beam across the 
treatment field, at gantry angle 0°. Measured dose valucs were correctcd for the 
measured day-to-day dose variation in the center of the static lOx 10 cm' field, and 
(arbitrarily) normalized to the average corrected dose in the 80 days study period. As 
shown in figure 7.2, the variation in dose was only 0.4% (ISO), pointing at an 
excellent stability of the gap width in time «0.0 I cm). 
Figllre 7.1 
7cm 
Part of a verificatioll fillll IIsed to slIIdy the aCCl/racy of leaf 
positioning and gap widths. Tile arrows poillf at a line with a low 
optical dellsity alld a lille with a high optical dellsity, related to a 
slightly slIIal/er alld a slightly larger gap width thall illtellded. 
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Stability of the dose ill the celller of a uniform lOxiO em' field, 
realized by scanning a 0.4x10 em2 slit beam. The average measured 
dose i1l the 80 days study period was set to 100%. 
Dose measurements in uniform IOxlO cm' fields, realized with the sweeping 0.4 cm 
wide slit beam at gantry angles 0°, 90°, 180° and 270°, were used to investigate the 
variation in gap width subject to gantry rotation. After correction for the dose variation 
in the static IOxlO cm' field subject to gantry rotation, a maximum dose difference 
between the four gantry angles of 2% lVas found in the field center, indicating that the 
variation in gap width subject to gantry rotation is less than 0.0 I cm as well. 
7.3.2 Long term dosimetric stability 
The long term dosimetric stability was verified using one intensity modulated beam 
from a treatment plan for a prostate cancer patient, derived in a pre-clinical treatment 
planning study (see figure 7.3). The width of the field was 12 cm. To realize this 
intensity modulated field, 136 monitor units were delivered. 
In figure 7.4, the long term stability of the dose in the reference point of the intensity 
modulated field (sec figure 7.3), measured with the ionization chamber, is depicted, 
after correction for measured day-to-day dose variations in the center of a static IOxlO 
cm' field and (arbitrarily) normalization to the average cOlTected dose in the 100 days 
study period. The results show a variation of only 0.2% (I SO), which is within the 
accuracy of the measurements, indicating that the stability in dose for the DMLC 
treatment is similar to the variation in dose for a 'standard' treatment with a static field. 
Figure 7.3 
Figure 7.4 
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Optimized jluellce profile for a patieJlt witlt prostate cancer. To assess the 
long-term stability alld gantl}' angle dependence of relative dose profiles. 
measured profiles were normalized to tlte dose ;'1 tlte indicated reference 
poil1t. Tlte arrows indicate tlte positions of tlte measured dose profiles 
depicted ill figures 7.5 alld 7.6. 
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Long-term stability of the dose ill tlte reference poilll indicated ill figure 7.3. 
Tlte average measured dose ill the 100 days study period was set to 100%. 
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llol1l1alized to 100% in the reference poillt. The dashed lines show 
average profiles measured ill the 100 days period at the three off-axis 
positions indicated by the arrows ;11 figure 7.3. The error bars indicate 
the obsel1 led variations (±1 SD). 
In figure 7.5 average dose profiles (N=!7) at three off-axis positions, measured with 
the EPID and normalized to 100% in the reference point, are depicted by dashed lines. 
The error bars indicate the observed variations (±! SD) in the 100 days study period. 
Apart from regions with very large dose gradients, the variations in the relative dose 
profiles were generally less than I % (I SD), which is similar to the variation in dose 
profiles observed during our daily dosimetric quality control measurements for static 
fields (38). The larger dose variations at the field edges correspond to day-to-day 
variations in the measured beam penumbra of only ±O.03 el11, which are likely due to 
small variations in the alignment of the EPID box with respect to the isocenter position. 
7.3.3 Stability under gantry rotation 
The stability of delivered dose profiles under gantry rotation was investigated for a 
wide range of fluence profiles using 10 and 25 MV photon beams. Both ID model 
cases, i.e. with identical modulated profiles for all leaf pairs, and real 2D clinical cases 
were studied. 
For all gantry angles, the dose in the reference point, as measured with the ionization 
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chamber, reproduced within 0,2% (I SO) after con'ection for dose variations in the 
center of a static lOx 10 cm2 field subject to gantry rotation. The smailer ganhy angle 
dependence compared to the result mentioned in section 7.3.1 is related to the fact that, 
in contrast to that measurement, the sweeping leaf gaps were generally a few 
centimeters wide during OMLC delivery instead of 0.4 cm, reducing the impact of 
small deviations in the gap widths. 
For the intensity modnlated beam depicted in figure 7.3, the gantry angle dependence 
of the relative dose profiles (i.e. normalized at 100% in the reference point), measured 
with the EPID for a fixed collimator angle, is shown in figure 7.6. In this figure, the 
dashed lines show relative dose profiles measured at 0° gantry angle. Each error bar 
indicates the maximum of the local differences between the relative dose values 
measured at 90°, 180° and 270° and the corresponding dose value measured at 0°. 
Although no corrections were made for the potential gantry angle dependency of the 
beam profiles of corresponding static fields in this analysis, maximum deviations from 
gantry angle 0° of less than 1 % were generally observed, apart from regions with large 
dose gradients. Therefore, the influence of gravity on dose profiles delivered with 
OMLC should be less than I %. Similar results were derived from the measurements 
with the linear diode array. 
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Frequency histogram of the absen/ed deviations between the realized leaf 
positions as stored ill the log file and the prescribed leaf positions when 
realizing tilefluence profile indicated il/jigure 7.3 at gall/I)' angle 0". 
For a OMLC treatment at gantry angle 0°, figure 7.7 shows a frequency histogram of 
the detected deviations between the actual leaf positions as stored in the log file and the 
prescribed leaf positions. On average the leaves were positioned correctly within 0.01 
cm, while the deviations from the prescribed positions were only 0.023 cm (I SO). 
When delivering this OMLC treatment at gantry angle 90° (with all leaves traveling in 
the direction of gravity) or 180°, similar deviations were observed. Only at gantry angle 
270°, for which all leaves were traveling against gravity, an average shift of 0.03 em 
was observed with respect to the results in figure 7.7, showing that on average the 
leaves were traveling with a small time delay. As shown before in subsection 7.3.1, the 
gap width did not change significantly under gantry rotation, indicating that the 
deviation in leaf positioning is similar for both the left and the right leaves when 
traveling against gravity. As a result, the (rather small) deviations did not affect the 
dose profiles delivered with OMLC, as was also demonstrated by the results in figure 
7.6. After rotation of the collimator angle by 180°, similar deviations as for gantry 
angle 270° were also observed for gantry angle 90°. 
7.3.4 Sensitivity to treatment interrupts 
In figures 7.8a and 7.8b dose profiles measured during an uninterrupted OMLC 
treatment are depicted, after normalization to the dose in the center of the flat profile 
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Dose profiles measured for an uninterrupted treatment. 
A1easured dose differences behl'een all uninterrupted treatment mid a 
treatment during wllich tile leaves were forced to stop three times due 
to (manual) interrupts. The arrows 1-3 indicate the positions where the 
right alld left leaves were forced to stop. Figure c corresponds to figure 
a al/djigure d to jigure b. 
(not depicted). The results were compared with profiles measured during treatments in 
which the leaves were forced to stop three times due to (manual) interrupts. In figure 
7.8c and 7.8d dose differences with respect to the corresponding uninterrupted 
treatment are depicted. Apart from regions with a steep dose gradient, these differences 
were generally less than ±l %, which is within the uncertainty of the film 
measurements. Even when leaves were traveling at maximum leaf speed at the time of 
treatment intermpt. increased deviations with respect to the unintermpted treatment 
were not observed, indicating that deceleration and acceleration of the leaves have a 
negligible influence on the realized flllence profiles at the MM50, as was also 
concluded before by Spirou and Chui [135]. The results also demonstrate that a DMLC 
treatment can be completed correctly after an interrupt by the control system of the 
treatment machine has OCCUlTed. 
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7.4 Conclusions 
The results described in the present and the previous chapters show that the accuracy 
and stability of leaf positioning in DMLC mode and the dosimetric accuracy and 
stability of intensity modulated beams, generated at the MM50 by means of dynamic 
multi leaf collimation, is adequate for clinical introduction. Clinical application of 
DMLC for head and neck cancer patients and prostate cancer patients has recently 
started. As part of our quality control program, a method for pretreatment verification 
of the absolute beam f1uence profiles for all treatment fields of a patient has been 
developed using our portal imaging device [77]. The procedure, which is described in 
the next chapter, simultaneously verifies the mechanical and dosimetrical performance 
of the treatment unit, the calculation of the dose distribution by the treatment planning 
system, which results from derived leaf trajectories, and the conect transfer of the leaf-
sequencing file to the treatment machine. In the near future an on-line, independent 
verification of the realized leaf trajectories will be implemented whieh derives the 
actual leaf positions in each camera frame acquired during the treatment and, in 
combination with the number of delivered monitor units, calculates the differences with 
respect to the prescribed leaf positions [5,118]. 
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Dosimetric verification of intensity modulated beams produced 
with dynamic multi leaf collimation using an electronic portal 
imaging device 
Adopted from the original article by KL Pasma, MLP Dirkx, M Kroonwijk, AG Visser 
and BIM Heijmen, pnblished in Med. Phys. 26: 2373-2378, 1999. 
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8.1 Introduction 
Dose distributions delivered by multiple field irradiation techniques can often be 
significantly improved by modulating the two-dimensional intensity profile of the 
individual x-ray beams [12,16,17,56,68,91,104,114,134,137,164,166-168]. One 
technique to realize intensity modulated (1M) beam profiles, calculated by means of 
inverse treatment planning, is the use of dynamic multileaf collimation (DMLC) 
applying the 'sliding window' technique [29,40,135,138,147,158]. For this technique an 
algorithm for calculating the required leaf trajectories was presented in chapter 6. In 
1995 the first group of patients was irradiated using DMLC at Memorial Sloan-
Kettering Cancer Center, NY [86]. Recently, treatment of head and neck cancer 
patients with DMLC has also started in our clinic. 
A disadvantage of the dynamic technique is that it is difficult to verify due to its 
complexity. Bortfeld et al have therefore proposed to produce intensity modulated 
beams by superpositioning a number of partially overlapping, static, irregularly shaped 
fields produced with the MLC [13]. Controlling the delivery of a sequence of small 
doses and static leaf settings was considered to be a straightforward extension of 
existing linear accelerator control. However, compared to DMLC generally longer 
treatment times are required for the static technique. 
For verification of segmented beam delivery Curtin-Savard and Podgorsak proposed 
the use of the scanning liquid ionization chamber EPID [32]. Without a patient in the 
beam, portal images were acquired for each subfield of the leaf sequence and converted 
into a dose rate distribution. Subsequently, the images were converted into absolute 
dose distributions by multiplication with the corresponding monitor unit setting. 
Finally, the individual dose distributions were summed to produce a dose distribution at 
the measurement depth. These distributions were then compared with dose 
distributions predicted by a treatment planning system. Because of the use of the 
monitor unit setting, the comparison with the dose distribution of the treatment 
planning system is basically a verification of the relative dose distribution. The applied 
EPID is relatively slow in returning to its initial state. Therefore, a 60 s rest interval 
between measurement of subsequent segments had to be applied, yielding long overall 
measurement times of typically one hour. Due to the scanned signal readout and the 
measurement of dose rate instead of dose, the applied EPID is not suitable for high 
precision dosimetric verification of DMLC. 
To test the reproducibility and accuracy of DMLC, the use of film has been reported 
[90,92,164]. At Memorial Sloan-Kettering Cancer Center mm dosimetry is performed 
in a flat homogeneous phantom for each field prior to the first treatment. Measured 
dose distributions are compared with corresponding calculated dose distributions [92]. 
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A disadvantage of film dosimetry is that it is time consuming since it requires 
developing and scanning of the film. Moreover, a sensitometric curve is needed to 
convert optical densities into doses. 
CCD camera based EPIDs are a promising tool for verification of DMLC due to their 
high data acquisition rate and capability to measure simultaneously in all points of the 
treatment field [5,100,121,118]. Balter et 01 showed preliminary results of a method to 
derive leaf positions in each camera frame acquired during treatment delivery and to 
compare them with a table of prescribed leaf positions [5]. Leaf positions could be 
determined with an accuracy of 0.6 nUll and a duty cycle of less than I s. A similar 
approach waS implemented by Partridge et 01 [118]. They used a custom made EPID 
with image acquisition synchronized to the accelerator magnetron current pulse 
production, with one CCD camera frame acquired per accelerator pUlse. Data were 
presented for a 6 MV beams. The accuracy of the leaf position measurements was 2 
mm. Due to a iimitation of the camera triggering hardware, the pulse rate of the linac 
had to be reduced. Ma et 01 calculated normalized reference images from MLC leaf 
sequencing files and compared these with normalized images measured with a 
tluoroscopic beam imaging system (BIS, Wellhiifer Dosimetrie, Schwarzenbruck, 
Germany) for a 6 MV photon beam [100]. This imaging system can be fastened to the 
blocking tray holder of a linear accelerator. It was especially designed for quality 
control tasks. Fol' calculation of the reference image a measured portal image of a large 
open field was used. The reference image was therefore not only related to the 
prescribed tluence, but also contained optical distortions in the EPID system. A global 
correlation coefficient was used to compare the calculated reference image with the 
image measured with the BIS. This method can be used to verify whether leaf 
sequencing tiles have been transferred correctly to the linac control computer and 
whether the treatment can be correctly executed without machine faults. Transmission 
through the leaves (both intraleaf and interleaf) was not taken into account and a 
simple empirical method was used to model extrafocal scatter. Despite these 
limitations, they concluded that it was possible to detect uncertainties of less than 0.05 
cm in leaf positioning during DMLC. 
The above described methods to verify leaf motion cannot be used to check whether 
the calculated leaf trajectories do indeed generate the absolute beam tluence profiles 
used in treatment planning. In this paper a new method is presented for a pre-treatment 
verification of these absolute beam fluence profIles utilizing a commercially avai1able 
CCD camera based tluoroscopic EPlD. In the absence of the patient EPID images are 
acquired for all beams produced with DMLC. These images are then converted into 
two-dimensional dose distributions and compared with calculated dose distributions. 
The calculations are performed with a pencil beam algorithm as implemented in a 
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commercially available treatment planning system using the same absolute beam 
f1uence profiles as used in the treatment planning system for calculation of the patient 
dose distributions. In this paper results are presented for intensity modulated 10 and 25 
MV photon beams; both model cases and real clinical cases were studied. Absolute 
dose profiles measured with the EPID were also compared with ionization chamber 
measurements. Preliminary results on measurements of absolute dose distributions in 
1M fields produced with DMLC have been reported [121]. 
8.2 Materials and methods 
8.2.1 EPID and ionization chamber dose measurements 
The applied EPID is a Philips SRI-IOO (Philips Medical Systems), which basically 
consists of a tluorescent screen, two mirrors and a CCD camera. The fluorescent screen 
is a 1.65 nllll thick stainless steel plate coated with a layer of gadolinium oxysulphide. 
To reduce the detection of high-energy electrons generated in patients, an extra I mm 
thick stainless steel slab has been mounted on the standard t1uorescent screen [121]. 
The added slab hardly affects the image quality [76). The acquired images may be used 
both for set-up verification and for ill vivo dosimetry [77,123). The EPID has a fixed 
focus to fluorescent screen distance of 160 cm. Technical details of the EPID have 
been described by Visser et al and Althof et al [1,163). 
Image acquisition is performed with a procedure written in the macro command 
language that comes with the system. The integration time on the CCD chip was set to 
2401118 and 120 camera frames were accumulated in the frame store memory. The read 
out time needed to transmit a frame from the CCD to the frame grabber (during which 
no signal is accumulated) is 80 ms. The final image is the mean of the integrated 
camera frames, corrected for the dark current measured prior to the irradiation. In the 
original procedure image acquisition starts automatically when the measured pixel 
values in the center of the camera frame exceed a threshold, i.e. when the beam is 
switched on. For the DMLC measurements described in this paper, image acquisition 
was started manually, since the leaves block the pixels in the center of the image at the 
start of the irradiation, when using the sliding window technique. The procedure was 
discussed in detail by Pasma et al [121). 
Due to sagging of the EPID structure, the field center can shift slightly. To correct the 
image for this shift, the position of the field center was derived using the position of the 
field borders in an EPID image of a (static) square field and was stored in a lookup 
table. Raw EPID images of 512x256 pixels were then resampled to arrays of 64x64 
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elements; each element represents a region of interest with an area of 0.5xO.5 cm' 
projected at isocenter. Conversion of these arrays into absolute dose distributions was 
performed in three steps. Acquired images were first corrected for the non-linear 
response of the system [118,121]. Subsequently, the image was corrected for the 
optical 'cross talk' by dcconvolving it with a point spread tilllction [59,121]. Finally, 
the resulting array was divided by an array that accounts for relative EPID sensitivity 
[121]. The system was calibrated once. The observed day-to-day variation of the EPID 
response per unit of delivered dose is 0.4% (I 0') [122]. Due to radiation damage to the 
CCD chip the EPIb response gradually decreases (-3%/year) [123]. Tlus decrease was 
carefully monitored and corrected for by using the daily acquired itnages for the quality 
control of the absolute output and field flatness of the scamung photon beams of the 
MM50 (see chapter 2) and the two weekly output checks with an iOluzation chamber. 
Dose measurements were also performed with a N31002 iOluzation chamber (PTW, 
Freiburg, Germany). The ionization chamber was inserted in a polystyrene mini-
phantom [118] at a depth of 2.0 cm for the 10 MV beam and at 2.5 cm for the 25 MV 
beam. For those depths, it was experimentally found that the variations in the on-axis 
response of the EPID (EPID pixel value/portal dose measured with the ionization 
chamber were minimal for field sizes ranging from 3x3 up to 18xl8 cm' and 
polystyrene absorber thicknesses ranging from 0 up to 35 cm. For a 25 MV photon 
beam the mean of the standard deviations of the EPID response for all field sizes was 
0.4% [121]. The mini-phantom was scanned in an empty RFA-300 water phantom 
(Scanditronix Medical AB) with the center of the ionization chamber positioned at a 
distance of 160 cm from the focus, which is equal to the fixed focus to tluorescent 
screen distance of the EPID. 
8.2.2 Calculation of the dose distribution at the detector 
Starting point for the calculation of the dose distribution at the fluorescent screen of the 
detector is the optinuzed beam fluence Fopt (x, y) (in MU) to be delivered at positions 
(x, y), which is the result of a computer optimization or inverse treatment planning. 
Using the iterative algorithm described chapter 6, leaf trajectories are then calculated, 
taking into account collimator scatter and the effective leaf transmission, which is the 
SUln of the transmission through the leaves and the extra focal radiation under the 
moving leaves, and avoiding tongue-and-groove underodage effects [158]. Gcnerally 
less than 10 iterations are necessary to minimize the difference between the optimized 
tluence profilcs Fopt(x,y) and the realized tluence profiles F(x,y), wluch are used for 
calculation of the final dose distribution in the patient with the CadPlan 3D treatment 
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planning system (Varian-Dosetek). 
The expected absolute dose distribution in the plane of the fluorescent screen of the 
EPID in absent of a patient, Dp.o(x,y), is calculated from the realized fluence profile 
using the pencil beam algorithm as implemented in the CadPlan treatment planning 
system [140,142], In the current implementation (CadPlan v2.7.9) the penumbra width 
is a linear function of the SSD. As a result, the predicted dose distributions would 
become inaccurate for the SSD of the detector (160 cm), which is much larger than the 
SSDs clinically used. Therefore, the dose distribution is calculated at 100 cm from the 
focus by enlarging the field with a factor of 1.6 (16011 00). The dose distribution is then 
normalized using the calculated on axis dose in a static 16xI6 cn,> field for 150 MU. 
Finally, the absolute dose distribution is calculated using the measured cGy/MU value 
at the detector for a lOx I 0 cm' field. Dose calculations and the calibration 
measurement are performed at a water depth of 2 cm for the 10 MV photon beam, and 
at a depth of 2.5 cm for the 25 MV beam, equal to the effective measuring depths of 
the EPID, as discussed in section 8.2.1. 
8.2.3 Realization and verification of fluence profiles 
Measured and predicted dose distributions Dp.o(x,y) were compared for the 10 and 25 
MV photon beams of the MM50 Racetrack Microtron. For the IOMV beam the dose 
rate was 200 MU min-I and for the 25MV beam 300 MU min-I. The microtron 
produces 200 radiation pulses per second. For all measurements the leaves moved from 
left to right parallel to the x-axis. 
The developed method was tested for a range of fluence profiles; both model cases and 
real clinical cases were studied. Calculated absolute dose distributions (section 8.2.2) 
were compared with dose distributions derived from EPID images (section 8.2.1) and 
with dose profi1es measured with an ionization chamber. The axes for comparisons in 
the leaf direction were chosen at the center of each leaf pair (y= ±0_6, ±1.9, ±3.1, .. ). 
Throughout the paper positions and distances arc defined at the plane normal to the 
beam axis at 100 em from the focus. The reported differences are the lllean deviation in 
percent and the corresponding standard deviation in percent (i.e. mean ± 1 a). 
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8.3 Results 
In figures 8.1 and 8.2 data are presented for intensity modulated 10 MY beams. Within 
the treatment field the leaf trajectories were identical for all leaf pairs; the presented 
data are for y=O.6 cm. Outside the penumbra region, both beams show an excellent 
agreement between EPID and ionization chamber measurements; the difference is only 
O.3±O.6% (figure 8.1) and O.I±O.8% (t1gure 8.2). The actual agreement may even be 
slightly better, since each ionization chamber measurement required the complete 
irradiation to be repeated. 
Figure 8.1 
Figure 8.2 
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As concluded in the previous chapter, the short-term reproducibility of the absolute 
dose delivery with DMLC at the MM50 Racetrack Microtron is 0.2%. The deviations 
between the calculated dose profile and the profile measured with the EPID are -2.1± 
1.2% and 0.9±0.8%, respectively. 
The data presented in figure 8.3 are for a beam fluence profile that was also used to 
generate the data in figure 8.2, but now was realized with the 25 MY beam. Again 
deviations between EPID and ionization chamber measurements are small: O.2±I.3%. 
The deviation between the predicted dose profile and the profile measured with the 
EPID is -1.0±0.7%. Similar results were found for the profile presented in figure 8.4: 
0.2±1.0% and -1.0±1.4% respectively. 
Figure 8.3 
Figure 8.4 
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In figures 8.5a and b acquired EPID images (512x256 pixels) for two non-square 1M 
25 MV beams are shown. The fiuence decreases in the y-direction; the dose at the top 
of the image is a factor of 2.2 lower than at the bottom. Due to the synchronization of 
leaf trajectories of adjacent leaves, underdosage (lower pixel values) do not occur in 
the overlap regions [158]. The small overdosage (higher pixel values) in the overlap 
regions of adjacent leaves are due to the interleaf leakage of about 2% (see section 
6.4.3). These overdosages can be avoided using partial synchronization [169]. 
Figures 8.5c and d show cross sections along the y-axis (normal to the axis along 
which the leaves move) of the two-dimensional dose profile derived from the EPID 
images shown in tlgures 8.5a and b respectively. Corresponding predicted dose proilies 
and dose profiles measured with an ionization chamber are included. For the first lleld 
(figure 8.Sa) the deviation between EPID and ionization chamber measurements was 
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O.2±1.l % and for the second field (figure 8.Sb) 0.4±2.0%. The deviations between the 
predicted profile and the EPID measurements were -O.9±1.7% and -1.4±1.7%, 
respectively. 
Standard deviations are slightly increased due to the interleaf leakage that was 
measured but not taken into account in the calculations. Under the center of the leaves 
the deviations are -O.7±1.2% and -0.4±1.6%, respectively. 
In figure 8.6 results are presented for a two-dimensional 1M profile designed for 
treatment of a prostate cancer patient. The deviation between the predicted profile and 
the profile measured with the EPIO is O.S±1.1 %. 
Figure 8.6 
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8.4 Discussion and conclusions 
A procedure for pre-treatment verification of absolute beam t1uence profiles realized 
with DMLC was developed and tested. The time required to verify an 1M beam is 
about two minutes, which is much shorter than any other dosimetric technique. The 
EPID system only has to be calibrated once. The agreement between calculations and 
EPID measurements and between BPID and ionization chamber measurements was 
within 2% (lcr). The procedure allows an overall verification of (i) the calculation of 
the final dose distribution, corresponding to the calculated leaf trajectories (including 
the models to incOlporate collimator scatter and leaf transmission), (ii) the correct 
transfer of the leaf sequencing tile to the treatment machine and (iii) the mechanical 
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and dosimetrical performance of the treatment unit. It is not always possible to 
distinguish between these types of errors using only portal llnages. Previously 
published OMLC verification methods with EPIDs only verified leaf motion [5,118] or 
relative dose prot1les [100]. The excellent agreement between our EPID and ionization 
chamber measurements in all cases shows that the read out time of 80 ms (during 
which no signal is collected) has no detectable effect; the data acquisition rate is 
sufficiently high [100]. 
In the near future the developed method will be extended to enable verification of 
OMLC durlllg patient treatment. Acquisition of portal images suitable for dosllnetric 
verification of OMLC can be fully integrated into existing imaging routines for patient 
set-up verification, without introducing an increase in the overall treatment time [77]. 
Preliminary results on measurements of portal dose images (POI), i.e. the dose 
distribution behind a patient in a plane normal to the beam axis, in an 1M beam have 
been reported [121]. The calculation of a POI for a patient irradiated with an IM beam 
is a relatively sllnple extension of existing methods [120]. The relation is 
Op(x,y)=Op.o(x,y) • T(x,y), with Op(x,y) the predicted portal dose at position (x,y) 
beneath the patient, Op.o(x,y) the predicted portal dose in absence of the patient (as 
described in section 8.2.2), and T(x,y) the predicted transmission through the patient 
using the planning CT-data. [123]. A potential problem is to distinguish between 
deviations in predicted and measured POls due to machine faults and differences due 
to deviations between the patient anatomy during acquisition of the planning CT scan 
and during treatment delivery. For prostate cancer patients we have observed that 
deviations in patient anatomy introduce large local differences between predicted and 
measured POls [77]. Machine faults arc likely to produce a constant difference over the 
whole irradiation field. In case of malfunctioning of a single leaf, the difference will be 
limited to the beam's eye view of that leaf. 

Chapter 9 
General discussion 
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9.1 Introduction 
The main objective of this thesis was the development and clinical implementation of 
intensity modulated treatment techniques using a multileaf collimator. Secondly, fast 
methods for dosimetrical quality control of (i) intensity modulated treatment fields, and 
(ii) an advanced treatment unit like the MM50 were developed, which were based on 
measurements with an electronic portal imaging device (EPID). 
In this section, the clinical application of different techniques for delivery of intensity 
modulated beams using a multileaf collimator will shortly be reviewed and advantages 
and disadvantages will be summarized. Next, the impact of treatment uncertainties in 
intensity modulated radiotherapy (IMRT) will be discussed in more detail. Finally, the 
issue of dosimetrical quality control of IMRT will be addressed. 
9.2 Clinical implementation of IMRT techniques using a 
multileaf collimator 
9.2.1 Static intensity modulation techniques 
The use of static intensity modulation does not necessarily require inverse treatment 
planning; improved treatment plans may also be achieved by using forward planning. 
Examples have been described in chapter 3 and 4 of this thesis. At the University of 
Michigan, the use of static intensity modulated treatment teclmiques based on forward 
planning started already in 1994. In their treatment plamllng system UmPlan, special 
tools for defining segments within a treatment field were implemented in order to 
achieve a homogeneous dose distribution in the target volume [50]. For each treatment 
field, generally only small numbers of additional segments (I or 2) were required, 
thereby minimally increasing the treatment delivery complexity and treatment time. 
They have implemented multi-segmented intensity modulation for nearly all tumor 
sites, including prostate, liver, abdomen, lung, breast and chest wall, head and neck and 
brain [44,50]. They use this technique in dose escalation studies, e.g. for patients with a 
brain tumor in which the dose to the central part of the tumor volume (GTV +0.5 cm 
margin) has step-wise been increased from 70 to 100 Gy, without increasing the dose 
to the outer PUtt of the planning target volume and the sUlTounding normal brain tissue 
[150,162]. A similar technique of static beam intensity modulation has also been 
implemented by Picket et al to escalate the dose to regions inside the prostate with 
tumor cells, as defined by the combined use of magnetic resonance imaging (MRI) and 
magnetic resonance spectroscopy (MRS), to 90 Gy, without increasing the dose to the 
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rectum and the bladder [126]. 
Another approach for implementing segmented intensity modulation by means of 
forward planning techniques has been developed by de Neve ef al for various tumor 
sites [36,37]. For treatment of tumors with a similar geometry and anatomical location 
they defined class solutions, describing the beam parameters, penumbra margins and 
segmentation rules to be used for plan optimization. Segments were designed based on 
the patient anatomy, thereby increasing the number of segments in the vicinity of the 
projection of sensitive structures. Recently, automatic optimization tools have been 
developed to assign weights to individual beam scgments using a biophysical object 
function [34]. 
Clinical introduction of step and shoot techniques based on inverse planning started 
only a few years ago. At this time this technique is used for different tumor sites at a 
limited number of centers around the world, like in Heidelberg [127] and San F1'ansico 
[160]. 
9.2.2 Dynamic intensity modulation 
Clinical application of dynamic multi leaf collimation for realization of intensity 
modulated fields started in 1995 at Memorial Sloan-Kettering Cancer Center, NY at a 
Varian accelerator. Originally they used the technique in their dose escalation study for 
prostate cancer patients [90,179], but in the meantime the application has been 
extended to other tumor sites, like primary nasopharynx cancer [61]. In our clinic 
dynamic multileaf collimation was introduced clinically in 1999 for treatment of head 
and neck cancer patients at the MM50 Racetrack Microtron, replacing compensators, 
which were used before [155]. Recently, we have implemented this technique for 
treatment of prostate cancer patients as well, using the inverse planning module Helios 
in our treatment planning system Cadplan for calculation of optimized fluence profiles. 
9.2.3 Rotational intensity modulation techniques 
Clinical application of the Peacock MiMiC started in Houston in 1994 [55]. Since then, 
the system has been introduced in many other institutes, especially in the United States. 
Till now only one system has been installed in Europe, at the University Hospital of 
Brussels [159]. The system is especially suited for treatment of patients with brain and 
head and neck cancer, but other tumor sites like prostate cancer have been treated as 
well [55]. 
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Last year, the clinical use of intensity modulated arc therapy (!MAT) using a multileaf 
collimator has been started at the University of Maryland Medical School for treatment 
of patients with head and neck cancer [178]. 
·9.2.4 Comparison of techniques for intensity modulation with a MLC 
Each of the different techniques described before has advantages and disadvantages. 
Compared to dynamic multileaf collimation, static intensity modulation is often 
assumed to be implemented more easily and safely in clinical practice, considering it a 
straightforward extension of the use of the multileaf collimator as a static beam shaping 
device. But static multileaf collimation generally requires longer treatment times, 
because the beam is interrupted during the set-up of the different MLC segments. To 
reduce the overall treatment times for the step-and-shoot technique, improvements have 
recently been made in accelerator design by several manufactures, allowing a faster set-
up and verification of succeeding subfields, taking a few seconds only. However, to 
reach acceptable treatment times it still remains important to limit the number of 
segments for each treatment field, yielding a resolution limitation. 
Compared to static intensity modulation, optimized intensity modulated fields can often 
be realized more precise by using dynamic multileaf collimation, especially when the 
optimized fluence profiles have steep dose gradients. It is still under debate whether 
this is clinically relevant or not. In a treatmeut planuing study for different brain 
tumors, Keller et al [72] showed that differences ill the final dose distribution were 
only very small when realizing each treatment field by dynamic multileaf collimation 
or by the superpositioning of 5 to 7 static beam segments. 
For static intensity modulation, leaf-sequencing algorithms may yield very small beam 
segments or segments with isolated leaf openings. To achieve accurate dose delivery, 
this puts high demands on the mechanical accuracy of the MLC, on the applied dose 
calculation algorithms and on models to include collimator scatter effects. For dynamic 
multileaf collimation this problem may be avoided to a large extend by synchronizing 
the leaf trajectories [158,169]), which also avoids tongue-and-groove underdosage 
effects. 
Compared to static and dynamic intensity modulation with a limited number of beam 
angles, rotational intensity modulation techniques are often capable in producing 
superior dose distributions [160], because they offer a higher degree of freedom to 
avoid sensitive structures by spreading out the dose over other normal structures. 
However, due to the slice-by-slice approach, intensity modulation with the Peacock 
MiMic generally requires much longer treatment times compared to static and dynamic 
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intensity modulation techniques. Moreover, slice-by-sliee intensity modulated beam 
delivery, as with the Peacock MiMic, is very sensitive to patient movements during the 
treatment. Small patient movements of only 1 mm can already result in errors in the 
delivered dose of 25% or more [23,96]. These disadvantages do not apply to IMA T. 
Because most of the target will be in the beam while rotating the gantry, treatment 
delivery with IMAT is rather efficient. For most clinieal sites, an optimal treatment 
requires less than five arc rotations, making the delivery time of IMAT comparable to 
the time required for conventional treatment techniques [15,178]. Moreover, the patient 
does not need to be moved during the treatment, avoiding the problem of beam 
abutmcnt between slices and the risk of undcr- or overdosages related to that. Finally, 
IMA T can be implemented on an existing linear accelerator with an MLC, without 
requiring additional hardware. 
9.3 Impact of treatment uncertainties in IMRT 
In chapters 3 and 4 a BIM technique was presented for penumbra enhancement around 
the superior and inferior field edges. Sharper beam penumbrae were realized by 
delivering additional beam fluence in the most superior and inferior parts of the 
treatment field. Similarly, inverse treatment planning techniques often yields optimized 
fluence profiles with increased fluence levels at the edges of the treatment field and 
close to the projection of sensitive structures. Due to the shaper beam penumbrae, 
smaller penumbra margins may be applied for definition of the treatment fields, 
yielding a reduced dose delivery to surrounding normal tissues. As a result, the use of 
intensity modulation allows for a (further) reduction in the risk of side effects for 
several tumor sites and for dose escalation in the treatmcnt of others. However, to 
avoid geometrical misses of the target volume, the smaller treatment fields put higher 
demands on the accuracy of the definition of the GTV and the CTV and the inclusions 
of adequate margins between the CTV and the PTV to account for patient set -up 
inaccuracies and internal organ motion [62]. 
9.3.1 Delineation of the target volume 
A CT scan is still generally used for definition of the target volume. However, due to 
insufficient visibility and contrast in the CT images and the difficulty to define the 
extend of potential microscopic spread of the tumor, large variations in target 
delineation have been reported for various tumor sites, both between different 
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physicians and between several delineations of one physician at different times [24,48, 
87,133,152]. Often, the accuracy of the target definition can be improved by adding 
other imaging modalities like MRI, MRS, PET or SPECT [3,111,128,149]. Because 
these modalities lack information on electron densities, which is required for treatment 
planning, delineated volumes should always be transferred to a CT scan. To minimize 
the risk of errors in this process, automatic 3D matching tools to overlay images of 
different modalities, which have becn developed by several groups [73,125,157], 
should become more generally available. Furthermore, new protocols and procedures 
should be developed to use these imaging modalities to achieve a reduction in tumor 
delineation variations. 
9.3.2 Set-up accuracy and organ motion 
In the past decade many studies have been performed to quantify the accuracy of 
patient set-up using megavoltage imaging with a portal imaging device. Both off-line 
[7,8,33] and on-line correction [3,35,97,154,146] protocols have been developed to 
reduce set-up crrors, which should be taken into account when defining the PTV. For 
safe application of IMRT the use of these techniques will become more cl1lcial. As an 
extension of the verification technique described in the previous chapter, a study will 
be started in our clinic to combine the use of megavolt age imaging for patient set-up 
verification with in-vivo dosimetry during DMLC treatments, allowing verification of 
the actual dose delivery of intensity modulated beams during patient treatment. 
A problem with megavoltagc imaging is that the tumor volume itself is generally not 
visible in the portal images. Instead the geometrical verification of the tumor is often 
based on surrounding bony structures. A solution for this problem is to implant radio-
opaque markers in the tumor volume [3,9,161], but this is not easily possible for all 
tumor sites. It is conUllon that treatment plans are designed using a single CT scan of 
the patient. However, to be able to compensate for inter-fraction motion, additional CT 
scans can be made at the first treatment days. In the William Beaumont Hospital, this 
technique is used to design an effective PTV, formed by the hull of the delineated 
tumor volume in the initial treatment planning CT scan and in 4 succeeding scans 
[171]. Depending on the observed intra-fraction variations, one decides whether a 
patient is suitable for llvIRT and/or dose escalation. For those patients a new treatment 
plan is then designed based on the effective PTV. Another approach, which might be 
suitable especially for patients with larger inter-fraction motions, is to acquire a CT 
scan prior to each treatment fraction. To enable this, a helical CT scanning capability 
will be available in the tomotherapy unit that is being developed at the University of 
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Wisconsin [49]. At William Beaumont Hospital a kilovoltage cone beam CT option 
has been installed at one of their accelerators, which allows for the generation of full 
volumetric CT slices after one gantl)' rotation, without the need of patient displacement 
[64]. 
In recent years several methods have been developed to incorporate the impact of 
patient set-up errors and organ motion in the final dose distribution [98,106,145]. 
Application of this technique may be very important, especially when applying IMRT, 
since more accurate information on the actual dose delivery during an entire treatment 
course for both the target volume and normal tissues lying nearby is obtained and 
potential over- or underdosages can be quantified. Moreover, algorithms which 
incorporate (random) errors for patient set-up and organ motion in the inverse planning 
process have been published [88,91] 
When delivering intensity modulated beams, one should also be aware of the impact of 
intra-fraction organ motion e.g. due to respiration. In contrast to static field treatments 
without intensity modulation, where intra-fraction organ motion only effects the field 
boundaries by broadening the effective dose fall-off, the interplay of organ motion and 
field shape variation during an lMRT treatment can distort the desired fluence profile 
within the treatment field significantly, yielding under- or overdosages up to 100% 
[177]. This problem is not only restricted to dynamic and rotational treatments; 
significant hot and cold spots may also arise at the boundaries of subfields which are 
superimposed in static intensity modulation techniques. To minimize the organ motion 
due to respiration, the use of the deep-inspiration breath hold technique [58] 01' active 
breathing control [170] is proposed. Especially for lung cancer patients, these treatment 
techniques are not always well tolerated. Alternatively, the treatment delivery can be 
gated, by switching on the treatment device at a predetermined phase of the breathing 
cycle, and switching it off at other phases [78,79]. But gating will result in a prolonged 
treatment time. 
9.3.3 Geometrical misalignment of the treatment unit parameters 
Geometrical misalignment of treatment unit parameters may have a large impact on the 
dose delivered within an intensity modulated field. Especially a high accuracy in leaf 
positioning is required to avoid under- or overdosages [20,92]. When using dynamic 
multileaf collimation, the dose delivered in the treatment field is directly related to the 
width of the sliding gap sweeping across the treatment field, as explained in chapter 7. 
Based on simulations, Budgell et at recently concluded that the realization of intensity 
modulated beam profiles, calculated by inverse planning, definitely require a leaf 
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position accuracy better than 1 mm, to avoid large dose errors, both in regions with a 
relatively homogeneous beam profile and in regions with high dose gradients [20]. As 
was demonstrated in chapter 7 and by others [20,92], modern control systems of a 
multileaf collimator allow for a stability in leaf positioning well within 0.01 cm. 
Therefore, the leaf position accuracy is mainly affected by the accuracy of the leaf 
calibration, which should be verified regularly, e.g. on a two-weekly basis. For this 
purpose, a quality control test using a narrow sweeping leaf gap, as proposed by 
LoSasso [92] and applied in chapter 7, is very useful, allowing deviations in leaf 
calibration of 0.05 cm to be detected. Additionally, as was shown in chapter 7, the 
stability in gap width may be verified within 0.0 I cm by performing dose 
measurements in a uniform field. realized by sweeping a 0.4 em wide slit across the 
field. 
The impact of misalignment of the gantry and collimator angle on dose distributions 
delivered by IMRT has been investigated, both for single beams on a phantom [94] and 
for clinical multi-beam treatment plans [30,174]. The magnitude of dose errors due to 
gantry misalignment increase proportional with the distance to the isocenter plane; in 
the isocenter plane itself no dose errors exist. For a single beam, dose errors of more 
than 10% may be observed at 10 cm from the isocenter plane when the gantry angle 
has been misaligned by 1° [94]. These dose errors do not only occur at the boundaries 
of the treatment field, like for static fields, but also inside the treatment field, especially 
for highly modulated fluence profiles. To minimize the errors associated to gantty 
angle misalignment, the isocenter should therefore be placed close to the center of the 
target, if possible. Misalignment of the collimator angle has a smaller impact on the 
dose distribution and the dose crrors arc mainly concentrated to the boundaries of the 
treatment field. In the studies of Convery and Rosenbloom [30] and Xing et at [174] 
the impact of angular misalignments on dosimetric quantities. like the minimum, 
maximum and average doses and dose volume histograms for the target and sensitive 
organs was investigated for clinical treatment plans. They demonstrated that errors in 
gantry and collimator angle positions of less than 10 have only small impacts on the 
delivered dose distribution for clinical IMRT plans. In contrast, the accuracy of patient 
positioning was demonstrated to be of much greater importance. 
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9.4 Dosimetrical verification of IMRT 
9.4.1 Verification by dose measurements 
Within the treatment field, intensity modulated beams, calculated by inverse treatment 
planning techniques, generally show large variations in the optimized fluence profile. 
For dose calculations, this puts higher demands on the accuracy of the algorithms 
implemented in treatment planning systems. At this time, the different leaf sequencing 
algorithms that were developed have only been validated for a limited number of 
treatment fields and tumor sites. Moreover, the delivery of intensity modulated beams 
by either of the methods described in section 9.2 is certainly more complex compared 
to conventional treatments. For these reasons a pre-treatment dosimetrical verification 
of the intensity modulated beams for each individual patient is definitely required for 
the time being. In literature, two different approaches have been described. In the t1rst 
approach, the dose distribution for individual treatment t1elds is verified by using tIlm, 
ionization chambers, TLD or a portal imaging device [21,100,122]. For each beam 
direction, the measured dose distribution is then compared with the calculated dose 
distribution resulting from the expected fluence protlle of the optimized beam. A 
second approach is the verification of the entire IMRT plan at once by irradiating some 
special phantom with all intensity modulated t1elds [95,127,151], In this phantom 
measurements may be performed simultaneously ~t different parallel planes using film, 
TLD andlor ionization chambers. Also gel dosimetry has been applied for quantifying 
the accuracy of the 3D dose distribution [110,117]. Measured dose distributions are 
compared with calculated dose distributions in the phantom using the fluence maps and 
beam directions, which result li'om the optimized treatment plan of the patient. 
Because an accurate verification of the entire treatment plan of a patient is most 
relevant, application of the second approach seems to be preferred. For rotational 
techniques, it is probably also the only practical solution to verify the dose delivery. 
However, the treatment plan of a patient is not verifIed directly, because the phantom 
and the patient are generally quite differently shaped. Consequently, there is no direct 
correlation between the accuracy of the phantom measurements and the patient 
treatment plan. Moreover, due to the contribution of all treatment fields to the Iinal 
dose distribution, reasons for observed deviations between calculated and measured 
dose protlles are often hardly identit1ed. In case single t1elds are verilled the 
interpretation of observed differences between measured and calculated dose 
distributions is more straightforward, especially when a flat, homogeneous phantom 
perpendicular to the beam axis is lIsed for the measurements. 
The process of dosimetrical verification of IMRT plans should be fast and accurate to 
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allow a large number of patients to be Ireated safely with IMRT, without requiring 
excessive effort and time for quality control. In contrast to other measurement 
techniques like fihn, the use of an electronic portal imaging device is a very powerful 
tool for absolute dosimetry in this respect, as was demonstrated in chapter 8. Using this 
method accurate verification of absolute 20 dose distributions is possible within a few 
minutes. 
9.4.2 Independent verification of monitor units for IMRT 
Generally the Humber of monitor units required for a patient treatment is calculated by 
the treatment planning system. As part of the quality conlrol program these numbers 
are often verified using an independent calculation method. But, in contrast to 
conventional treatments, an intuitive verification of the Humber of monitor units is no 
longer possible for IMRT due to Ihe increased complexity of the treatment technique. 
Algorithms for monitor unit verification, which are presently used for conventional 
treatments, do not apply for IMRT either. Therefore, as part of the patient specific 
quality control, the absolute dose delivered to a patient by intensity modulated llelds is 
generally verified by dose measurements in a phantom, as described before. Recently, 
methods that are suitable for monitor unit verification for IMRT have been described, 
applying the leaf sequencer file (which, like for the MM50, includes the leaf settings 
for each MLC subfield and the cOlTesponding number of monitor units) to be used for 
the patient treatment [80,173]. In the future a similar, independent check of the monitor 
units to be delivered in each treatment field might replace the dose measurements for 
individual patients. 
9.5 Concluding remarks 
Although the clinical application of IMRT is still limited around the world, new 
implementations are rapidly increasing nowadays, because of the improvements that 
can be achieved in terms of dose delivery to the nUllOr volume and sensitive stmctures. 
Due to the increased complexity, clinical implementation of IMRT is labour intensive 
at this stage, limiting the number of patients that can be treated with this technique. In 
the next couple of years, methods for planning, delivery and automatic verification of 
IMRT treatments will certainly be extended and further integrated, allowing this 
technique to be applied for larger numbers of patients and lumor sites. 
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Introduction 
Although investigations on computer optimization of radiotherapy treatment planning 
(inverse planning) have demonstrated that dose distributions can often be conformed 
tightly to a target volume by customizing the beam intensity profiles within the 
treatment Held, clinical application of intensity modulated radiotherapy has just been 
started in a limited number of institutes around the world. At the Daniel den Hoed 
Cancer Center studies on the development and clinical implementation of intensity 
modulated conformal radiotherapy started after clinical introduction of the MM50 
Racetrack Microtron. Both static and dynamic intensity modulation using a multileaf 
collimator were investigated. Results of these studies have been described in this 
thesis. 
Static beam intensity modulation 
In axial co-planar treatments with multiple Helds, the penumbrae of the superior and 
inferior Held edges of all treatment fields overlap, yielding broad overall penumbrae in 
these regions. Therefore, large field margins are generally needed for definition of the 
superior and inferior field borders (0 avoid underdosages in the superior and inferior 
ends of the planning target volume (PTV). Chapters 3 and 4 deal with a technique for 
penumbra enhancement at the superior and inferior field edges using static beam 
intensity modulation (BlM). The intensity modulated x-ray beams, generated with a 
multileaf collimator, include narrow boost Helds to increase the dose in the superior 
and inferior ends of the PTV. Due to penumbra enhancement the length of all treatment 
Helds could be reduced, while still achieving a minimum dose in the PTV of 95% of 
the prescribed dose. As a result of the reduced Held lengths, the dose delivery to critical 
structures could often be reduced. The benefits of this BlM technique with respect to 
our (previous) standard technique have been assessed in a treatment planning study for 
prostate cancer patients (chapter 3) and lung cancer patients (chapter 4), using our 
Cadplan 3D treatment planning system. For prostate cancer patients application of the 
BlM technique allowed a Held length reduction of 1.6 cm, generally yielding smaller 
volumes of rectum and bladder in the high dose region. For lung cancer patients the 
field lengths could be reduced by 1.4 cm for all patients. Due to reduced dose delivery 
to the healthy lung tissue, application of BlM allowed a potential for dose escalation of 
6 to 7 Gy on average, without increasing the predicted incidence of pneumonitis. For 2 
of the 12 patients in the treatment planning study, the estimated allowed dose 
escalation even exceeded 15 Gy. All dose escalations would be possible without 
exceeding the spinal cord tolerance dose. 
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The accuracy of our Cadplan treatment planning system for calculating dose 
distributions for the BIM technique was validated by dose measurements. Relative dose 
distributions for the narrow boost fields generally agreed within 2% or 2 nnn with dose 
distributions, which were calculated by Cadplan. For accurate monitor unit 
calculations, the phantom seatter table as used in Cadplan had to be modified using 
measured data for square fields smaller than 4x4 cm'. 
In the treatment planning study for lung cancer patients a treatment planning system 
was used that did not correctly account for the increased lateral secondary electron 
transport in lung tissue. Therefore, before starting clinical implementation of the BIM 
technique for lung cancer patients, extensive dosimetricalmeasurements were required 
(i) to assess the accuracy of our Cadplan 3D treatment planning system for the 
proposed ElM technique in lung treatments, (ii) to adapt the proposed BIM technique 
to account for increased lateral electron transport, and (iii) to define practical rules for 
designing treatment plans with the Cadplan treatment planning system. The results, 
presented in chapter 5, show that, by increasing the length and the weight of the boost 
fields applied in the ElM technique, to compensate for increased lateral secondary 
electron transport in lung tissue, a field length reduction of 1.4 cm is indeed possible. 
Practical rules could be derived for designing the BIM plans using our Cadplan 
planning system. 
Rcduced dose delivery to critical structures with the proposed BIM technique, related 
to the decreased superior-inferior field lengths, is not typical for the treatment 
techniques applied in our clinic; improved treatment plans are to be expected for all co-
planar techniques. Nowadays, BlM is routinely applied in our clinic at different 
treatment units for treatment of prostate cancer patients and head and neck cancer 
patients. Thc extra time needed for set-up and delivelY of the boost fields is usually less 
than I minute. Treatment plans for the BlM technique are easily obtained by 'forward' 
treatment planning; sophisticated computer optimization algorithms are no~ required. 
Dynamic beam intensity modulation 
Chapter 6 describes an algorithm for the calculation of the required leaf trajectories to 
generate optimized intensity modulated beam profiles by means of dynamic multileaf 
collimation (DMLC). The algorithm iteratively accounts for leaf transmission and 
collimator scatter, and fully avoids tongue-and-groove underdosage effects. The 
accuracy of this algorithm in combination with the dose calculation algorithm of our 
Cadplan treatment planning system has been assessed by comparing absolute dose 
distributions for optimized fluence profiles with dose distributions measured on the 
MM50 Racetrack Microtron, using the calculated leaf trajectories. Both theoretical and 
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clinical cases generally yielded an agreement \vithin 2%, or 2 mm in regions with a 
high dose gradient, showing that the accuracy is adequate for clinical application. As a 
final test before starting patient treatment using dynamic multi leaf collimation, the 
stability of intensity modulated beam profiles, generated at the MM50 Racetrack 
Microtron using DMLC, was investigated, (i) in time, (ii) subject to gantry rotation and 
(iii) in case of treatment interl1Jpts, e.g. caused by an error detected by the treatment 
machine. The resuits, presented in chapter 7, show that the absolute dose in a 
reference point, situated in a relatively flat part of the beam prome, reproduced within 
0.2% (lcr) over a period of 100 days. During this period variations in the relative beam 
profiles were generally less than 1% (l cr), except for regions with very large dose 
gradients. A similar reproducibility was measured for different gantry angles, showing 
that gravity has a negligible influence. No significant deviations between uninterrupted 
and interrupted treatments could be observed, indicating that the effects of acceleration 
and deceleration of the leaves are negHgible and that a DMLC treatment can be 
finished correctly after a treatment intenllpt. In the meantime, patient treatment using 
dynamic multileaf collimation has been started in our clinic at the MM50 for head and 
neck cancer patients and prostate cancer patients. 
Dosimetric quality control using an EPID 
A complex treatment machine like the MM50 Racetrack Microtron definitely requires 
extensive dosimetric quality control. Chapter 2 describes a method for fast and daily 
dosimetrical checks of the absolute output and the beam fluence profile of scanned 
photon beams at different gantry angles using an electronic portal imaging device 
(BPIO). Open beams are checked for four gantry angles and for gantry angle 0° a 
wedged field is checked as well. The performance and analysis of the measurements 
take less than 10 minutes. It is demonstrated that the applied BPI!) is well suited for 
these dosimetrical measurements due to its excellent stability, linearity and 
reproducibility. Daily measurements over a ten months period have demonstrated that 
the 2D fluence profile of the 25 MV photon beam of the MM50 is very stable in time, 
showing a maximum deviation of 2.8%. In this period, a deviation in the absolute 
output of 6% was detected once, proving the importance of these daily checks, because 
no interlock in the MM50 would have prevented patient treatment with this strongly 
deviating output. Based on the results of this study, and on clinical requirements 
regarding acceptability of deviations of beam characteristics, a protocol for these daily 
tests was developed, including action levels for additional investigations and, if 
necessary, adjustments of beam characteristics. 
Delivery of intensity modulated beams using dynamic multileaf collimation is rather 
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complex and therefore reqnires extensive qnality control before patient treatment is 
started. In chapter 8, a new method for pre-treatment verification of all intensity 
modulated beam profiles for a patient is presented based on absolute dose 
measurements with a fluoroscopic electronic portal imaging device. Prior to the first 
treatment fraction of the patient an EPID image is acquired for each treatment field and 
then converted into a two-dimensional dose distribution. This dose distribution is 
compared to a dose distribution calculated with the pencil beam algorithm as 
implemented in our Cadplan treatment planning system, using the same absolute beam 
fiuence profile as used for calculation of the patient dose distribution. The method 
allows an overall verification of (i) the calculation of the dose distribution by the 
treatment planning system, using the leaf trajectories derived with the algorithm 
described in chapter 6, (ii) the correct transfer of the leaf sequencing file to the 
treatment unit, and (iii) the mechanical and dosimetrical performance of the treatment 
machine. For both theoretical and clinical examples using 10 and 25 MY photon 
beams, the accuracy of this method for pre-treatment verification was demonstrated by 
an agreement within 2% (I cr) between both calculated dose distributions and EPID 
measurements and between EPID and ionization chamber measurements. The time 
required to verify an intensity modulated beam is about 2 minutes, which is much 
shorter than for other dosimetrical techniques. 
IMRT in clinical practice 
[n the general discussion of the last chapter different methods to realize intensity 
modulated beam profiles using a multileaf collimator are compared. Because in IMRT 
the dose delivery is generally more closely conformed to the tumor volume, the 
position of the tumor volume during treatment delivery should be well known. Some 
uncertainties that are related to this, like the accuracy of target delineation, the patient 
setup accuracy and detection of internal organ motion, are discussed. Finally, the 
dosimetrical veritlcation of lMRT is addressed in more detail. 
I 
I 
I 
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Inleiding 
Bij de toepassing van radiotherapie voor behandeling van patienten met kanker gaat het 
erom dat er voldoende dosis wordt afgegeven in het tllmorvoillme om de tllmorcellen te 
doden en dat de dosis in het gezonde weefsel zo laag mogelijk wordt gehollden om de 
kans op bijwerkingen van de behandeling te beperken. Onderzoek naar de toepassing 
van computeroptimalisatie bij het maken van behandelplannen Vaal' radiotherapie 
(inverse planning) heef! aangetoond dat het gebruik van patientspecifieke 
intensiteitsgemoduleerde bundelprofielen over het algemeen de beste mogelijkheden 
biedt om de dosisafgifte te beperken tot het tllmorvolume. Echter tot op heden wordt 
intensiteitsgemoduleerde radiotherapie (IMRT) wereldwijd slechts in een beperkt 
aautal behandelcentra toegepast. 
Na de ingebruikname van het MM50 Racetrack Microtron, een bestralingsapparaat dat 
uitcrmate geschikt is Vaal' de toepassing van geavanceerde bestralingstechllieken. zijn 
binnen de Daniel den Hoed Kliniek studies van start gegaan naar de ontwikkeling en 
klinische impiemcntatie van IMRT. Hierbij is zowcl statische als dynamischc 
intensiteitsmodulatie middels een multileaf collimator onderzocht. Dit proefschrift 
beschrijft de resultaten van dit onderzoek. 
Stalische intensiteitsmodulatie 
In axiale, coplanaire bestralingen met meerdere velden overlapt de dosisafval aan de 
craniale en caudale zijde van ieder bestraHngveld, hetgeen resulteert in minder scherpe 
totale dosisgradienten. Bij de bepaling van de bestralingsvelden in craniale en caudale 
richting moeten hierdoor meestal brede veldmarges worden toegepast om te 
voorkomen dat de ll1eest craniale en caudale gedeeltes van het beoogde doelvolull1e 
(PTV) ondergedoseerd worden. In de hoofdstukken 3 en 4 wordt een techniek 
beschreven, gebruikmakend van statische bundel intensiteitsmodulatie (BIM), waarll1ee 
scherpere dosisgradiCnten kunnen worden gerealiseerd in cranio-caudale richting. In 
deze B1M techniek wordt in de meest craniale en cauelale gedeeltes van het PTV extra 
dosis afgegeven door gebruik te maken van smalle velden, die worden gevonnd 
middels de ll1uHileaf collimator, met een laag gewicht. Ais gevolg van de scherpere 
dosisgradienten kan de lengte van ieder bestralingsveld worden gereduceerd, terwijl in 
het PTV toch minimaal 95% van de voorgeschreven dosis wordt afgegeven. De 
reductie van de veldlengte leidt veelal tot een venl1inderde dosisafgifte in het gezonde 
weefse!. Met het Cadplan 3D planningsysteem zijn studies uitgevoerd om de voordclen 
van de BIM techniek ten opzichte van de (oude) standaard behaneleltechniek te bepalen 
bij patienten met prostaat- en longkanker. Toepassing van de BIM techniek maakt bij 
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patienten met prostaatkanker (hoofdstuk 3) een reductie van de lengte van ieder 
bestralingsveld met 1.6 cm mogelijk, waardoor over het algemcen een kleincr deel van 
blaas en rectum een hoge dosis krijgt. Bij patienten met longkanker (hoofdstuk 4) kan 
de lengte van ieder bestralingsveld met 1.4 cm worden verminderd, met als gevolg een 
lagere dosisafgifte in gezand longweefsel. Toepassing van de BIM techniek biedt 
daannee de mogelijklleid om de dosis in de tumor met gellliddeld 6 tot 7 Gy te 
verhogen, zonder het risico op bijwerkingen (pneunomitis) te vergroten. Voor twee van 
de twaalf patienten in de planningstudie bleek zelfs een verhoging van de tUlllordosis 
met meer dan 15 Gy mogelijk. Voor aile patienten was deze verhoging van de 
tUlllordosis mogelijk zander dat de tolerantiedosis van het l1Iggenmerg werd 
oversclll'eden. 
am de nauwkeurigheid te bepalen waarmee het Cadplan planningsysteem de 
dosisverdelingen voor de BIM techniek berekent, zijn er dosismetingen verricht in 
water. De gemeten relatieve dosisverdelingen voor de smalle boostvelden kwamen 
over het algemeen binnen 2% of 2 mm overeen met de dosisverdelingen die door 
Cadplan werden berekend. am een correcte absolute dosisberekening te krijgen moest 
de tabel met fantoom scatterfactoren die door Cadplan wordt gebruikt, worden 
aangepast Vaal' velden kleiner dan 4x4 cn{ 
De toename van het laterale elektroncntransport in weefsel met een lage 
elektronendichtheid, zaals longweefsel, wordt door het planningsysteem Cad plan niet 
correct in rekening gebracht. Alvorens over te gaan tot klinische toepassing van de 
BIM techniek bij patienten met longkanker werd er daarom eerst een nitgebreid 
dosimetrisch onderzoek uitgevoerd. Het doel van deze studie was om (i) vast te stellen 
wat de nauwkeurigheid is van de dosisvoorspellingen voor de BIM techniek door 
Cadplan, (ii) te bepalen hoe de BIM techniek moet worden aangepast om te corrigeren 
voor het toegenomen laterale elektronentransport inlongweefsel, en (iii) om praktische 
regels vast te stellen waannee BIM behandelplanncn voor patientell met longkanker 
met Cadplan kunllell worden gemaakt. De resultaten van deze shIdie, beschreven in 
hoofdstuk 5, laten zien dat de lengte en het gewicht van de boostvelden, die in de BIM 
techniek worden toegepast, moeten worden vergroot am te compenseren Vaal' de 
toegenomen laterale elektronenverstrooiing. In dat geval blijkt een reductie van de 
veldlengte met 1.4 cm inderdaad mogelijk, zonder dat er delen van het PTV worden 
ondergedoseerd. 
Reductie van de dosisafgifte in kritieke organen, als gevolg van een verminderde 
cranio-caudale veldlengte, door toepassing van de beschreven BIM techniek, is niet 
typisch voor de bestralingstechnieken die in ons instituut worden toegepast. Verbeterde 
behandelplannen kunnen worden verwacht voor aile coplanaire bestralingstechnieken. 
Momenteel wordt de. BIM techniek veelvuldig toegepast in ons institnnt bij de 
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bestraling van patienten met KNO- en prostaattumoren op verschillende bestralings-
toestellen met een multileaf collimator. De exira tijd voor het instellen en afgeven van 
de boostvelden is meestal minder dan een minuut. Behandelplannen voor de BIM 
techniek kUllllcn eenvoudig worden verkregen met 'voorwaartse' planning. 
Gecompliceerde computeroptimalisatie algoritmen zijn hiervoor niet vereist. 
Dynamische intensiteitsmodulatie 
In hoofdstuk 6 is een algoritme bescln'even om de leafbewegingen te berekenen 
IVaarmee een geoptimaliseerd intensiteitsgemoduleerde profiel middels dynamische 
multileaf collimatie (DMLC) kan worden gerealiseerd. Yia een iteratieve berekenings-
methode corrigeert dit algoritme voor transmissie door de leaves en collimator 
verstrooiing. Daarnaast wordt voorkomcn dat er in het overlap gebicd van twee 
llaastliggende leaves onderdoseringen ontstaan ais gevolg van de 'tongue-en-groove' 
constl1lctie. De nauwkeurigheid van dit algoritmc in combillatie met het Cadplull 
planningsysteem is bepaald door voor een groot aantal intensiteits-gemoduleerde 
profielen absolute dosisverdelingen te berekenen en deze te vergelijken met 
dosisverdelingen die op de MM50 werden gemeten, gebruikmakend van de berekende 
leafbewegingen. Yoor wwel theoretische als klinische intensiteitsprotlelen komen 
gemeten en berekende dosisprofiel over het algemeen binnen 2% overeen, behalve in 
gebieden met een sterke dosisgradient waar een overeenkomst binnen 2 nnn wordt 
gevonden. Yoor klinische toepassingen is deze nauIVkeurigheid voldoende. 
Alvorens dynamische lllultileaf collimatie klinisch toe te gaan passcl1, is de stabiliteit 
van intensiteitsgemoduleerde velden, die op de MM50 worden gerealiseerd middels 
dynamisehe multileaf collimatie, onderzocht, (i) gedurende een langere tijdsperiode, 
(ii) bij bestraling vanuit verschillende bundelhoeken, en (iii) na onderbreking van de 
bestraling, bijvoorbeeld vanwege een door het bestralingstoestel gedetecteerde fout. De 
resultaten van dit onderzoek zijn beschreven in hoofdstuk 7. Gedurende een periode 
van honderd dagen blijkt de absolute dosis in een referentiepunt, gelegen in een relatief 
vlak gedeelte van een intensiteitsgemoduleerd veld, binnen 0.2% (lcr) te reproduceren. 
Bhmen deze tijdsperiode waren de relatieve dosisprofielen meestal binnen 1% 
reproduceerbaar, behalve in gebieden met een grote dosisgradiCnt. Yoor bestralingen 
vanuit verschillende bundelhoeken werd een vergelijkbare reproduceerbaarheid in de 
dosisprofielen gcmcten, wat aantoont dat dc' zwnurtekracht cen verwaarloosbare 
invloed heeft. Ook waren er geen aantoonbare verschillen tussen dosisprofielen die 
werden gemeten bij een ononderbroken en onderbroken bestraling. Hiel1lit blijkt dat 
versnelling en vertraging van de leaves geen noemenswaardige invloed heen op de 
leafbewegingen en dat een DMLC bestraling correct kan worden voltooid na een 
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onderbreking van de bestraling. Intussen is de klinischc toepassing van DMLC op de 
MM50 van start gegaan bij bestraling van patienten met KNO- en prostaattumoren. 
Dosimetrische kwaliteitscontrole met een EPID 
Het klinisch gebruik van een complex bestralingstoestel als het MM50 Racctrack 
Microtron vereist een uitgebreidere dosimetrische kwalitcitscontrole dan veelal 
gebl1likelijk is. In hoofdstuk 2 is een methode besc1ireven waarmee dagelijks snel de 
absolute output en het bundelprofiel van een scannende fotonenbundel kunnen worden 
geverifieerd bij bestraling vanuit verschillende bundelhoeken, gebruikmakend van een 
megavolt afbeeldingsysteem (MV A). Open bundels worden geverifieerd voor vier 
bundelhoeken en voor een hoek wordt tevens een wig veld gecontroleerd. Het uitvoeren 
en analyseren van deze metingen neemt mindel' dan tien minuten in beslag. Door zijn 
uitstekende stabiliteit, Iineariteit en reproduceerbaarheid blijkt het MV A-systeem 
uitennate geschikt te zijn voor dosismetingen. Dagelijkse metingen gedurende een 
peri ode van tien maanden hebben aangetoond dat het relatieve bundelprofiel van de 25 
MV fotonenbundel van de MM50 zeer stabiel is. De maximale variatie in dosis bleek 
slechts 2.8% te bedragen. Gedurende deze peri ode werd eenmaal een afwijking in de 
absolute dosis van 6% aangetoond, hetgeen het belang van deze dagelijkse metingen 
bewijst, omdat geen van de alarmeringssystemen van de MM50 patientenbehandcling 
met deze sterk afwijkende output had voorkomen. Gebaseerd 01' de resultaten van dit 
onderzoek en de voor klinische toepassingen toelaatbare varia ties in bundel-
karakteristieken, is een protocol opgesteld voor de dagelijkse kwaliteitscontrole met 
MV A, waarin tevens wordt aangegeven bij welke afwijkingen aanvullend onderzoek 
noodzakelijk is en de bundelkarakteristieken zonodig moe ten worden aangepast. 
Patientenbehandeling met intensiteitsgemoduleerde velden middels dynamische 
multileaf collimatie, is tamelijk complex en vereist daarom uitgebreide kwaliteits-
controle alvorens een patientenbestraling van start gaat. In hoofdstuk 8 wordt een 
methode beschrevcn VOOf de dosimetrische verificatie van illtensiteits-gemoduleerde 
bundels, die wordt uitgevoerd met een MVA-systeem. Voor de eerste bestraling van 
een patient wordt voor ieder bestralingsveld cen MV A-beeld opgenomen. Het MVA-
beeld wordt omgerekend naar cen absolute 2D dosisverdeling die wordt vergeleken 
met de voorspelde dosisverdeling voor het betreffende bestralingsveld. De 
dosisvoorspelling wordt gedaan met het algoritme dat ook in het Cad plan 
planningsysteem gei'inplementeerd is, gebl1likmakend van hetzelfde absolute 
bundelprofiel dat oak voor de berekening van de dosisverdeling in de patient wordt 
toegepast. Deze methode biedt de mogelijk om gelijktijdig (i) de berekening van de 
dosisverdeling door het planningsysteem te verifieren, die is gebaseerd op de 
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leatbewegingen die met het in hoofdstuk 6 besclueven algoritme worden afgeleid, (ti) 
te controleren of de file waarin de berekende leafbewegingen worden beschreven 
correct naar het bestralingstoestel is overgestllurd, en (iii) te bepalen of het 
bestralingstoestelmechanisch en dosimetrisch correct is afgesteld. Yoor 10 en 25 MY 
fotonenbundels blijken, voor zowel theoretische als klinische intensiteitsgemoduleerde 
velden, de voorspelde dosisverdelingen en de dosisverdelingen gemeten met MV A, en 
de dosisverdelingen gemeten met MY A en met een ionisatievat, binnen 2% (10) 
overeen te kamen. Dit toont de nallwkeurigheid van deze methode aan Vaal' 
dosimetrische controle van intensiteitsgemodllleerde velden. Per bundel kost deze 
cOlltrole ongeveer 2 minntcn, wat veel sneller is dan met andere dosimetrische 
meetteclmieken. 
IMRT in klinische praktijk 
In de algemene discussie in het laatste hoofdstuk worden verschillende technieken om 
intensiteitsgemoduleerde bundels middels een multileaf collimator te realism'en 
vergeleken. Doordat de dosisafgifte tijdens IMRT veelal beter tot het doelvolume kan 
worden beperkt, is het van groot belang dat de lokalisatie van de tumor tijdens de 
bestraling met grote nauwkeurigheid bekend is. Problemen die hierbij een rol spelen 
zijn ondermeer de intekennauwkeurigheid vall het tumorvolume, de positiollcrings-
nauwkeurigheid van de patient en de beweging van het doelvolume in de patient. Tot 
slot wordt nader ingegaan op de dosimetrische verificatie van IMRT. 
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Mijn dienstverband bij de Daniel den Hoed K1iniek begon op dezelfde dag dat ook de 
MM50 werd binnengehesen. Hoewel het idee om in een medische omgeving te gaan 
werken me op dat moment geweldig aansprak, had ik geen enkele ervaring met 
medische fysica of radiotherapie in het bijzonder. Ik kon dan oak niet vennoeden dat 
lnijn werk nu, ruim acht jaar later, zou gaan leiden tot deze promotie. Dat deze lnijlpijl 
nu tach bereikt is, heb ik mede te danken aan vele mensen met wie ik heb mogen 
samenwerkwerken, of die op andere wijze een bijdrage hebben geleverd aan de 
totstandkOlning van dit proefschrift. Enkele van hen wil ik hierbij in het bijzonder 
lloemen. 
In de eerste plaats wil ik mijn copromotor Ben Heijmen van harte bedanken. Als mijn 
directe begeleider heeft hij mij in de eerste periode wegwijs gemaakt binnen de fysica 
van de radiotherapie. Door Zijll enthousiasmc en gcdrevenheid wist hij me steeds weer 
te prikkelen tot het oppakken van nieuwe onderzoeksideeen. Vele interessante en 
lllotiverende discussies, die vaak tot vel' na werktijd doorgingen, Ingen hieraan ten 
grondslag. Met zijn gezonde, kritische blik heeft hij mij geschoold in het scln'ijven van 
artikelen. Zijn oprechte belangstelling voor en betrokkenheid bij het weI en wee van 
collegae, waardeer ik zeer. 
Bij de ontwikkeling van methoden voor dosimetrische kwaliteitscontrole met MV A 
heb ik prettig samengewerkt met Marco Kroonwijk, Hans de Boer en Kasper Pasma. 
Door het schrijven van software VOOf de EPID en Vaal' de analyse van meetdata hebben 
zij een belangrijke bijdrage geleverd aan dit onderzoek. Daamaast heeft Kasper het 
artikel uit hoofdstuk 8 van dit proefschrift gesclll'even. 
Eerdere onderzoeksresultaten en ontwikkelde software van Jan van Sal1tvoort waren 
zeer bruikbaar bij de implementatie van dynamische multileaf collimatie op de MM50. 
Onze vele discussies over IMRT in brede zin heb ik als plezierig en nuttig ervaren. 
Bij de uitvoering van de klinische planningstudies heb ik nauw samengewerkt met 
diverse laboranten en artsen, met name Ocrt Korcvaar, Mmjolcin van as, John van 
Stimsen de Koste, Suresh Senan, Peter Koper en lnijn promotor Peter Levendag. Mede 
door hun inbreng en de enthousiaste medewerking van de laboranten van de MM50 
wordt IMRT nu reeds enkele jaren toegepast in onze kliniek. De MM50 laboranten wil 
ik ook bedanken voor het vertrouwen dat ze in mij hebben gesteld. Ik hoop dat ik nag 
lange tijd lnijn rol als 'huisfysicus' naar behoren zal kunnen blijven vervullen. 
In de afgelopen jaren zijn op de MM50 talloze metingen uitgevoerd, zowel in het kader 
van dit onderzoek, als ook tijdens de commissioning van de MM50 en bij reguliere 
kwaliteitscontroles. Vooral Norman Driver, Erik Loeff, Ben Gtibel, Dirk Binnekamp 
en Mmjolein Idzes hebben hieraan een grote bijdrage geleverd. 
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Voor technische ondersteuning kon ik een beroep doen op mijn collegae van MEA, 
met name Peter Brusche, Hans Groen, Eric Sanderse, Willem Lamprecht en Hans 
Boul. Door hun ervaring en inzet konden problemen op de MM50 meestal snel en 
adequaat worden opgelost, zodat de down-tijd tot eenminimum beperkt bleef. 
Mijn naaste collegae wil ik bedanken voor de prellige, ontspannen, maar tevens 
stimulerende werksfeer op KFI. Door de jaren heen is er een sterke onderlinge band 
gegroeid, mede door gezamenlijke uitjes, met de jaarlijkse survival als hoogtepunt. 
In de afgelopen jaren heb ik een aantal stagiaires en afstudeerders van de Technische 
Hogeschool Rijswijk mogen begeleiden. Marco Kroonwijk, Ami van der Kamp, Karel 
van Ingen, Patrick van Gils en Gertjan van de Pol kunnen derhalve een deel van hun 
onderzoeksresultaten in dit proefscln-ift terugvinden. 
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